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O gene ataxin-3 (ATXN3; 14q32.1) codifica uma proteína expressa 
ubiquamente, envolvida na via ubiquitina-proteassoma e na repressão da 
transcrição. Grande relevância tem sido dada ao gene ATXN3 após a 
identificação de uma expansão (CAG)n na sua região codificante, responsável 
pela ataxia mais comum em todo o mundo, SCA3 ou doença de Machado-
Joseph (DMJ). A DMJ é uma doença neurodegenerativa, autossómica 
dominante, de início tardio. O tamanho do alelo expandido explica apenas 
uma parte do pleomorfismo da doença, evidenciando a importância do estudo 
de outros modificadores. Em doenças de poliglutaminas (poliQ), a toxicidade 
é causada por um ganho de função da proteína expandida; no entanto, a 
proteína normal parece ser, também, um dos agentes modificadores da 
patogénese. O gene ATXN3 possui dois parálogos humanos gerados por 
retrotransposição: ataxin-3 like (ATXN3L) no cromossoma X, e 
LOC100132280, ainda não caracterizado, no cromossoma 8. Estudos in vitro 
evidenciaram a capacidade da ATXN3L para clivar cadeias de ubiquitina, 
sendo o seu domínio proteolítico mais eficiente do que o domínio da ATXN3 
parental.  
O objetivo deste estudo foi explorar a origem e a evolução das retrocópias 
ATXN3L e LOC100132280 (aqui denominadas ATXN3L1 e ATXN3L2), assim 
como testar a relevância funcional de ambas através de abordagens 
evolutivas e funcionais. Deste modo, para estudar a divergência evolutiva dos 
páralogos do gene ATXN3: 1) analisaram-se as suas filogenias e estimou-se 
a data de origem dos eventos de retrotransposição; 2) avaliaram-se as 
pressões seletivas a que têm sido sujeitos os três parálogos, ao longo da 
evolução dos primatas; e 3) explorou-se a evolução das repetições CAG, 
localizadas em três contextos genómicos diferentes, provavelmente sujeitos a 
diferentes pressões seletivas. Finalmente, para o retrogene que conserva 
uma open reading frame (ORF) intacta, ATXN3L1, analisou-se, in silico, a 
conservação dos locais e domínios proteicos da putativa proteína. Ademais, 
para este retrogene, foi estudado o padrão de expressão de mRNA, através 
da realização de PCR de Transcriptase Reversa, em 16 tecidos humanos.  
Os resultados obtidos sugerem que dois eventos independentes de 
retrotransposição estiveram na origem dos retrogenes ATXN3L1 e ATXN3L2, 
tendo o primeiro ocorrido há cerca de 63 milhões de anos (Ma) e o segundo 
após a divisão Platirrínios-Catarrínios, há cerca de 35 Ma. Adicionalmente, 
outras retrocópias foram encontradas em primatas e outros mamíferos, 
correspondendo, no entanto, a eventos mais recentes e independentes de 
retrotransposição. A abordagem evolutiva mostrou a existência de algumas 
constrições selectivas associadas à evolução do gene ATXN3L1, à 
semelhança do que acontece com ATXN3. Por outro lado, ATXN3L2 adquiriu 
codões stop prematuros que, muito provavelmente, o tornaram num 
pseudogene processado. Os resultados da análise de expressão mostraram 
que o gene ATXN3L1 é transcrito, pelo menos, em testículo humano; no 
entanto, a optimização final da amplificação específica dos transcriptos 
ATXN3L1 permitirá confirmar se a expressão se estende a outros tecidos. 
Relativamente ao mecanismo de mutação inerente à repetição CAG, os dois 
parálogos mostraram diferentes padrões de evolução: a retrocópia ATXN3L1 
é altamente interrompida e pouco polimórfica, enquanto a ATXN3L2   
apresenta tratos puros de (CAG)n em algumas espécies e tratos 
hexanucleotídicos de CGGCAG no homem e no chimpanzé. A recente 
aquisição da repetição CGGCAG pode  ter  resultado de  uma mutação inicial 
  
 
de CAG para CGG, seguida de instabilidade que proporcionou a expansão 
dos hexanucleótidos.Estudos futuros poderão ser realizados no sentido de 
confirmar o padrão de expressão do gene ATXN3L1 e de detetar proteína 
endógena in vivo. Adicionalmente, a caracterização da proteina ataxina-3 like 
1 e dos seus interatores moleculares poderá povidenciar informação acerca 
da sua relevância no estado normal e patológico. 
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abstract 
 
Ataxin-3 gene (ATXN3; 14q32.1) encodes a ubiquitously expressed protein 
involved in the ubiquitin-proteasome pathway and in transcription repression. 
Much attention has been given to ATXN3 since the identification of an 
expanded (CAG)n tract in its coding region, responsible for the most common 
dominant ataxia worldwide, SCA3 or Machado-Joseph disease (MJD). MJD is 
an autosomal dominant, late-onset neurodegenerative disorder. The size of the 
expanded allele explains only part of the disease pleomorphism, highlighting 
the importance of studying other modifiers. In polyglutamine (polyQ) diseases, 
toxicity is caused by gain of function of the expanded protein; however, the 
normal protein appears to be one of the pathogenesis-modifying agents. 
The gene ataxin-3 has two human paralogues, generated by retrotransposition: 
ataxin-3 like (ATXN3L) on the X chromosome of humans and the yet 
uncharacterized LOC100132280 on chromosome 8. An in vitro study showed 
the ability of ATXN3L to cleave ubiquitin from their substrates, with its 
proteolytic domain even more efficient than the domain of the parental ATXN3.  
The aim of this study was to explore the origin and evolution of ATXN3L and 
LOC100132280 retrocopies (here named ATXN3L1 and ATXN3L2) and to test 
the functional relevance of both human paralogues through evolutionary and 
functional approaches. Thus, to study the evolutionary divergence of ATXN3 
paralogues, we have 1) analysed their phylogeny and estimated the time of the 
retrotransposition events; 2) assessed the selective constraints that have been 
underlying all the three paralogues over primate evolution; and 3) explored the 
evolution of the (CAG)n tracts placed on three different chromosomal 
backgrounds within paralogue genes that have, probably, been under different 
selective pressures. Finally, for the retrogene that conserved the ORF, 
ATXN3L1, we analyzed the protein domain conservation and the mRNA 
expression pattern by performing Reverse Transcriptase-PCR in 16 human 
tissues.  
Our results suggested that two independent retrotransposition events have 
been on the origin of ATXN3L1 and ATXN3L2, the first occurred about 63 
million years ago (MYA) and the second after the Platyrrhini-Catarrhini split, 
about 35 MYA. In addition, several other retrocopies have been found in 
primates and other mammals, but additional independent and younger 
retrotransposition events seemed to be on their origin. Our evolutionary studies 
suggested that ATXN3L1 has been under some selective constrains over 
primate evolution, as the parental ATXN3. ATXN3L2 gained premature stop 
codons that seem to have turned it into a pseudogene. In addition, we 
confirmed that ATXN3L1 is a transcriptionally-active retrogene since we 
observed mRNA expression, at least, in human testis. A refined optimization of 
the methodology to specifically amplify ATXN3L1 cDNA will be, however, 
necessary to assess the complete expression pattern of this retrogene. As for 
the (CAG)n tract, the ATXN3 paralogues presented different evolutionary 
patterns: ATXN3L1 showed a poorly polymorphic and highly interrupted tract 
across the primate lineage, whereas ATXN3L2 presented a pure (CAG)n in 
some species and a polymorphic hexanucleotide repeat in humans and 
chimpanzees. This recent acquisition of a repetitive CGGCAG resulted, 
probably, from a CAG to CGG mutation followed by instability that 
encompassed the six bases instead of the CAG alone.  
Future studies may be performed in order to confirm the expression pattern of 
ATXN3L1 and to detect the endogenous protein in vivo. Further 
characterization of ataxin-3 like 1 and its molecular interactors will give us 
insight into the actual relevance of this protein in normal and/or pathological 
states.  
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Chapter 1 
Introduction 
New genes are thought to contribute to the origin of adaptive evolutionary innovations and, 
thus, to lineage- or species-specific phenotypic traits. Traditionally, the origin of these new genes 
is associated with gene duplication, but other mechanisms have recently received increasing 
attention, such as retrotransposition, which may play an important role in mammal genome 
evolution.1, 2, 3 Retrotransposition consists in the re-integration of reverse transcribed mRNA 
molecules in the genome.4 At the sequence level, retroposed copies (retrocopies) can be intact or 
not, depending on the presence of mutations or premature stop codons. Still, if the open reading 
frame is conserved, retrocopies lack many of the genetic features of their parental genes (such as 
introns and regulatory elements) and, for this reason, they have been considered as confounding 
factors for a long time. Most retrocopies turned into pseudogenes in mammals, but some of them 
have recruited upstream regulatory elements and became functional (these are commonly called 
retrogenes).5 Indeed, many recent studies have shown that a larger part of retrotransposons than 
the previously predicted are functional, and that they can modulate other pre-existing cellular 
factors.1, 5  
This thesis project is focused on the study of two retrocopies of ataxin-3 (ATXN3), a 
ubiquitously expressed gene that codes a protein mainly involved in deubiquitination and in 
transcription repression. ATXN3 is also the gene responsible for Machado-Joseph disease (MJD), 
when its coding repetitive CAG tract is expanded above 61 repeats. MJD or spinocerebellar ataxia 
type 3 (SCA3) is a late-onset neurodegenerative disorder, characterized by a large pleomorphism. 
Thus, the search for disease modifiers has been a major point of interest in this disorder. 
The origin, features and functional relevance of the poorly studied ATXN3 retrocopies, ATXN3L 
and LOC100132280 (here named ATXN3L1 and ATXN3L2, respectively) remain completely 
unexplored until these days. With this project we aimed at characterizing ataxin-3 paralogues in 
the human genome and throughout the evolution to gain insight into the potential roles that they 
have been playing. 
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1.1 - Mechanisms of retroposition 
The key retrotransposition enzyme stems from different types of retrotransposable elements, 
depending on the organism. These elements can be subdivided in two groups, distinguished by 
the presence or absence of long terminal repeats (LTRs). In humans, LTR elements are 
endogenous retroviruses (HERVs), presently with very limited activity, which accounts for only 
~8% of the genome. On the other hand,  human non-LTRs include long interspersed nuclear 
element 1 (LINE 1 or L1), Alu and SVA (an element composed of a short interspersed region, a 
variable number of tandem repeats region and an Alu-like region - SINE/VNTR/Alu) elements, 
which collectively account for approximately one-third of the human genome (Figure 1).6   
 
 
 
L1, widely present in mammals (about 25% of their genome), are responsible for a burst on 
the number of retrocopies in mammalian lineages.2 These retrotransposable elements possess a 
reverse transcriptase and a endonuclease activity that can recognize any polyadenylated mRNA.7 
After gene transcription, the respective RNA is reverse-transcribed into DNA by the L1 elements, 
and the resulting cDNA is inserted into the genome at a new location (Figure 2).4, 7  
Figure 1 - Transposable and non-transposable element content 
of the human genome. About 33.7% of the human genome can 
currently be recognized as being derived from non-LTR 
retrotransposable elements (Cordaux et al., 2009).6 
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Figure 2 - Retrotransposition mechanism: a) retroposition is initiated with the transcription of a parental 
gene by RNA polymerase; b) a mature mRNA is produced, with the processing of the resulting RNA (by splicing 
and polyadenylation); c) L1 endonuclease domain (pink rectangle) mediates retroposition, by creating a first nick 
(yellow star) at the genomic site of insertion at the TTAAAA target sequence; d) this nick enables the mRNA to be 
primed for reverse transcription by the L1 reverse transcriptase domain (pink oval), which uses the parental 
mRNA as a template; e) second-strand nick generation, f) second DNA-strand synthesis; g) cDNA synthesis in the 
overhang regions created by the two nicks. (adapted from Kaessmann, 2009)1 
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To become expressed at a significant level and in a meaningful way, a new retrogene needs to 
obtain a core promoter and probably other elements, such as enhancers, that regulate its 
expression.1 Generally, the expression of a retrocopy might benefit from: 1) its insertion into 
intronic sequences of host genes, enabling it to be integrated into new splice variants of the host 
gene; 2) its insertion into actively transcribed regions with an open chromatin structure, as this 
increases accessibility for the transcriptional machinery; 3) the recruitment of distant promoters 
in the genomic neighbourhood via the acquisition of a new untranslated exon–intron structure; 4) 
the recruitment of proto-promoters from retrotransposons or CpG island; 5) the inheritance of 
parental promoters through alternative transcriptional start sites used by the parental gene; and 
6) de novo promoter evolution in the upstream flanking region of the insertion site by single 
nucleotide substitutions.1, 5 Since retroposed copies often need to recruit regulatory elements to 
become transcribed, they are prone to accumulate genetic variants and to evolve new expression 
patterns relatively to the traditional gene duplication. As a consequence, novel functional roles 
can emerge from the transcription of new formed retrogenes.1 Studies have revealed that 
retrogenes seem to evolve biased functions related to male functions, but others functions have 
also been described, for example, related to  the brain. 8, 9  
In addition, to be heritable and hence of evolutionary relevance, retrotransposition needs to 
occur in the germ line. The fact that retrotransposition relies on duplication through an mRNA 
intermediate implies that only genes expressed in the germ line can be the source of new 
retrocopies.1  
1.2- Machado-Joseph disease 
1.2.1 - Clinical presentation and epidemiology  
Machado-Joseph disease (MJD, also called spinocerebellar ataxia type 3, SCA3) is the most 
common type of spinocerebellar ataxia. SCAs are a large and complex group of late-onset 
diseases, characterized by progressive cerebellar dysfunction of afferent and efferent pathways, 
variably associated with other symptoms of the central and peripheral nervous systems. Other 
nervous system structures affected include the basal ganglia, brainstem nuclei, pyramidal tracts 
and post superior column and anterior horn of the spinal cord, as well as peripheral nerves.10, 11 
Although there are sporadic forms of ataxia, the term SCA is most often used to refer the 
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hereditary forms, and in particular the autosomal dominant ataxias.8 Nearly 30 subtypes of SCAs 
have been described, differently classified based on the underlying causative mutation. MJD is 
one of the polyglutamine diseases since the causative mutation is a CAG repeat expansion in 
ATXN3 gene, which encodes a stretch of glutamine amino acids in the corresponding protein.12, 13  
In the particular case of MJD, the major signs are the progressive cerebellar ataxia and 
pyramidal signs. Minor, but more specific, features are external progressive ophtalmoplegia, 
dystonia, intention fasciculation-like movements of facial and lingual muscles, as well as bulging 
eyes but these symptoms can vary among patients. The mean age at onset (AO) of the disease is 
around 40 years, although it can vary greatly, with extremes of 4 and 70 years.11 The mean 
survival time is 21 years (ranging from 7 to 29).14 Thus, MJD is characterized by a high degree of 
pleomorphism, not only in the variability of the AO, but also in the neurological signs presented 
and in the resulting degree of incapacity.10, 15  
SCAs are considered rare disorders, with estimated prevalence described as varying from 0.3 
to 2.0 per 100,000 individuals. The relative frequency of MJD among SCAs varies also largely 
among populations. It is higher in Brazil (69-92%),16 Portugal (58-74%),17 Singapore (53%),18 China 
(48-49%),19 the Netherlands (44%),20 Germany (42%)21 and Japan (28-63%)22 but even within each 
country, the geographic distribution pattern of MJD is not homogeneous.  
Haplotype-based studies have suggested that two independent-origin mutations may explain 
the current worldwide geographic distribution of MJD. The first occurred about 6000 years ago in 
Asia (TTACAC or Joseph lineage, observed in the 5 continents); and the most recent, with less than 
2000 years old, is responsible for the presence of MJD in Portugal (together with the most ancient 
mutation) and in a few other populations mostly linked to Portugal (GTGGCA or Machado 
lineage).23  
1.2.2 - Molecular genetics and pathogenesis  
ATXN3 gene 
ATXN3 was located in the long arm of chromosome 14 (14q32.1), by Takiyama in 1993.24 The 
genomic structure of ATXN3 spans about 48 kb, with the most frequent transcript containing 11 
exons.25 Two additional exons, 6a and 9a, have recently been described (Figure 3).26  
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The expansion of a (CAG)n tract within ATXN3 exon 10 is the causative mutation of MJD.
27 
Usually, wild-type alleles range from 12 to 44 CAG repeats, whereas expanded alleles comprise 61 
to 87 CAGs. Intermediate size alleles are rare, and their role in disease presentation is still under 
debate.28, 29  The size of the expansion has been found, until date, the parameter that best 
correlates with the AO of patients; however, it explains only 45-76% of AO variability suggesting a 
major influence of other factors.30, 31 Gender was initially proposed to be one of these factors32, 
but this was later contradicted, as familial factors were suggested to mask the gender effect.33 It 
was demonstrated, instead, that variation in AO accounted for an effect common to a sibship, 
independently of the CAG repeat length. Less controversial is the dosage effect on disease 
presentation: homozygous patients with two mutant alleles show, most frequently, a more severe 
disease phenotype, with earlier onset than those presenting only one mutated allele.34  
The process underlying the (CAG)n instability across successive generations is currently 
thought to involve the generation of abnormal DNA structures in replication slippage, as well as 
DNA repair and recombination, acting either separately or in combination.35 
Mechanisms of ATXN3 mutation  
The ATXN3 gene is present in a large range of living organisms, but the expansion seems to 
have occurred only in the human lineage, after the divergence from other hominids. A recent 
study in human ATXN3 has shown a bimodal distribution of (CAG)n alleles for all most frequent 
stable SNP-defined haplotypes. When flanking STR diversity was compared between modal (CAG)n 
alleles within each lineage, little differences have been noticed while alleles one or two repeats 
apart showed much higher genetic distances. Based on these results, a multistep mutation 
mechanism was suggested for the evolution of this locus in humans.36 Little is known, however, 
Figure 3 - ATXN3 gene structure, representing the first described exons and the two new exons: 6a and 
9a; the (CAG)n tract is localized in the exon 10. Transcribed regions are represented in blue, and not-
transcribed and UTR regions in grey.   (adapted from Bettencourt, 2011)13 
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about the mutation process underlying the evolution and instability over mammalian and even 
primate evolution that led to the currently observed (CAG)n tract configuration and level of 
polymorphism. In Pan troglodytes, Gorilla gorilla, Mus musculus and Gallus gallus, the repetitive 
tract in the ATXN3 gene is conserved, but shorter than in the human homologue.37  
Ataxin-3 protein and its physiologic role  
The ATXN3 gene encodes for ataxin-3, a protein with an approximate molecular weight of 42 
kDa (in its longest form) that is ubiquitously expressed in neuronal and non-neuronal tissues.25, 38  
In the human brain, ataxin-3 is widely expressed in different regions, with variable expression 
levels. Granular layer and purkinje cells of cerebellum, hippocampus, striatum and pyramidal cells 
of motor cortex seems to be the regions of higher expression levels, whereas mesencephalon 
(substantia nigra pars compacta), occipital cortex, globus pallidus (internal and external) and 
white matter of cerebellum present lower expression patterns.25, 38 In the Drosophila model, 
increased levels of the mutant ATXN3 expression have been shown to underlie more severe 
degeneration and earlier onset of protein accumulation, suggesting that abnormal accumulation 
of the mutant protein is central to disease and degeneration.39  
At the cellular level, ATXN3 was found to be present in the cytoplasm (mitochondria included) 
and nucleus, with varying degrees of predominance depending on the cell type.40, 41 In human 
brain cells, ATXN3 is present mainly in the perikarya, but it was also detected on proximal 
processes, axons and nuclei. This heterogeneity suggests that the regulation of ATXN3 expression 
levels and localization may have functional relevance.38 
ATXN3 participates in cellular protein quality control pathways but its biological function has 
not yet been completely understood. Studies in knockout mice for ATXN3 have demonstrated a 
cytoplasmic increase in ubiquitinated proteins, supporting an in vivo role of this protein in the 
ubiquitin/proteasome pathway as a deubiquitinating enzime (DUB).42, 43 The covalent attachment 
of ubiquitin to a protein is a reversible signal that can alter a protein’s function, control its 
trafficking, or mark it for degradation. Once attached, ubiquitin can be removed by DUBs, thereby 
generating a dynamic balance in ubiquitin signaling pathways.44 Ataxin-3 can also regulate its own 
cellular turnover in a ubiquitin-dependent manner; abolition of its catalytic activity disrupts this 
regulation.45 Hence, it is clear that ataxin-3 DUB activity is physiologically relevant. In addition, 
MJD mouse models have shown transcriptional deregulation, confirming a possible important role 
of ATXN3 in transcription.46 
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ATXN3 has a papain-like fold and is essentially composed by a structured globular N-terminal 
domain, followed by a flexible unfolded C-terminal tail. The N-terminal domain, designed Josephin 
domain (JD), displays ubiquitin (Ub) protease activity, while the flexible tail presents two or three 
Ub-interacting motifs (UIMs), depending on the isoform, and a polyQ region of variable length.47, 
48 Notably, the most common isoform found in the human brain has three UIMs in the C-terminal 
region (Figure 4).49  The highly conserved catalytic triad on the Josephin domain possesses the 
predicted catalytic aminoacids found in cysteine proteases: Cys14, His119 and Asn134.50 Two 
other serine residues are important in the UIM regions for the interaction with Ub: Ser232 in 
UIM1 and Ser260 in UIM2.51 
The Josephin domain is shared by three other human proteins (Ataxin-3 like, ATXN3L; 
Josephin-1, JOSD1; and Josephin-2, JOSD2), which together with ATXN3 form the Josephin family 
of DUBs.52  
 
 
 
A total of 56 human alternative splicing variants of ATXN3 have been identified with, at least, 
21 isoforms expected to be translated. The biological relevance of all these variants remains 
unknown.13, 53  
Polyglutamine expansion of ATXN3 and neural cell death  
The expanded ATXN3 gains a neurotoxic function through yet unclear mechanisms. In brains 
of MJD patients, ATXN3 forms nuclear inclusions (NI) present only in neurons, however, more 
recently axonal inclusions have also been observed in fibers known to degenerate.41 It is known, 
however, that this toxicity is linked to abnormal folding and aggregation of the mutant protein to 
itself as to other members of the cell quality control system, like proteasome constituents, 
ubiquitin and molecular chaperones.54, 55 Additionally, intracellular inclusions have been linked to 
the disease pathogenesis as a major means of gain of toxicity  by the expanded protein, through 
several possible mechanisms: a) hindrance of transcription, by direct decrease of gene expression 
regulation or through sequestration of other molecules involved in transcription regulation;56 b) 
transcription alteration via formation of histone-deacetylating repressor complexes on target 
Figure 4 - Ataxin-3 protein structure. UIM – ubiquitin interacting motif; PolyQ – poly-glutamine tract. 
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chromatin regions;57, 58 c) interference in the axonal transport, resulted from motor protein 
titration and physical blocking;59 and d) other disturbances caused by the recruitment of Ub-
binding proteins (since inclusions are heavily ubiquitinated) or other polyQ-containing proteins.60 
In contrast, NI have been recently suggested to play a protective role on MJD by sequestering the 
mutant proteins from the toxic interactions.61 
Although the polyQ expansion appears to be the triggering factor leading to the development 
of MJD, ATXN3 regions outside the polyQ, as well as other protein properties seem also to define 
the development of MJD and its particular aspects.  In animal and cellular models, the C-terminal 
fragment of expanded ataxin-3 alone was shown to be more toxic than the full-length protein, 
suggesting that ataxin-3 cleavage might be a contributor factor for the MJD pathology.62-64 Indeed, 
the ataxin-3 expanded polyQ tract was shown to exhibit several potential cleavage sites for 
caspases.65 Another study has also demonstrated a possible involvement of the N-terminal on 
MJD pathogenesis, since a mutant mouse model with an ATXN3 truncated form, containing only 
its N-terminal, presented typical neurological symptoms.66  
Therefore, clinical variability of MJD is only partially explained by the size of the (CAG)n tract 
and by the ATXN3 protein itself, which leaves a residual variance that should be explained by 
other unknown factors. In addition to the wild-type protein, the three other JD-like containing 
proteins may exert similar functions to ATXN3 and compensate for its absence in knockout 
models.52, 67 In fact, several studies on animal models have shown the importance of the normal 
non-mutated protein in the MJD pathogenesis. An interesting feature of non-expanded ataxin-3 is 
that it is also recruited to NI in several PoliQ diseases.68 In the Drosophila model, for example, 
normal ATXN3 has a neurodegeneration repression effect in vivo (a protective role) by retarding 
and reducing the accumulation of the pathogenic protein. This suppressor activity requires 
ubiquitin-associated activities at the normal protein, since, by mutating the two most important 
serine residues in UIM1 and UIM2 (Ser232 and Ser260, respectively), the ability of ataxin-3 to 
suppress degeneration become compromised.69   
1. 3 – Studies on the relevance of ataxin paralogues in SCAs 
Studies focusing on the modulation of parental genes by the respective expressed paralogues 
may be important to gain insight into the mechanisms by which ATXN3 retrocopies may be 
functional relevant. The gene responsible for spinocerebellar ataxia type 1 (SCA1), ATXN1, has an 
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evolutionary conserved paralogue called ATXN1-like. Recent studies in fly and mouse models have 
shown that the overexpression of ATXN1L partially suppresses the neuropathology caused by the 
polyglutamine-expanded ATXN1, by inducing sequestration of polyglutamine-expanded ATXN1 
into nuclear inclusions.70, 71 Similarly to MJD, molecular and genetic data suggested that SCA1 
pathogenesis is caused by a gain of function mechanism, while other studies have shown, 
however, that the deletion of wild-type protein enhances disease pathogenesis. In SCA1, 
additionally, it has been suggested that increased levels of the ATXN1L retrogene ameliorate the 
clinical phenotype. These data indicated that both gain and partial loss of function may contribute 
to the disease progress, with the partial loss of ATXN1 alone being sufficient to cause some 
transcriptional changes that are pathogenic in the cerebellum.70  
The mechanism underlying the functional relevance of ATXN1L may be related to the shared 
protein interactions by ATXN1 and ATXN1L. The two proteins were shown to share the 
transcriptional regulator Capicua (CIC) that is known to form complexes (Atxn1-CIC and Atxn1L-
CIC) that bind the promoters of target genes, repressing them effectively. Thus, in ATXN1-/- mice, 
the overexpression of ATXN1L rescues the level of stable complexes with CIC, maintaining its 
function as a transcription repressor. This mechanism is an evidence that transcribed paralogues 
can, in some degree, replace the loss-of-function observed in SCA1.70 Additionally, it was 
proposed that, as ATXN1L compete with wild-type and mutant ATXN1 for association with CIC, the 
increased levels of free mutant ATXN1 lead to an increase of aggregation and nuclear inclusions. 
70, 71 This data provide genetic evidence that evolutionary conserved paralogues may have an 
important role in the mechanisms of pathogenesis of neurodegenerative diseases. 
As for ATXN3 and MJD/SCA3, Weeks (2011) performed an in vitro study of the human ATXN3L 
retrocopy (here named ATXN3L1) by analysing the crystal structure of its predicted protein.52 The 
authors found that although ataxin-3 and ATXN3L adopt similar folds, they bind ubiquitin in 
different, overlapping sites. Additionally, by mutating ataxin-3 at selected positions (and 
introducing the corresponding ATXN3L residue), only three mutations were sufficient to increase 
the catalytic activity of ataxin-3. This suggested that ATXN3L Josephin domain could be 
significantly more efficient than the ataxin-3 domain itself, opening a broad road for further 
research concerning the study of this ATXN3 paralogue.  
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Aims  
Two human copies of the ATXN3 gene, formed by retrotransposition events, were recently 
discovered and annotated in databases. However, they remain unexplored as their description 
has not been received much attention. Therefore, we wanted to better characterize these 
retrocopies since, if transcribed, they may play a role in the pathogenesis of MJD.  Additionally, by 
comparing the (CAG)n tracts among the 3 paralogue sequences, we hope to gain insight into the 
repeat expansion mechanism that occurred at ATXN3 in the human lineage.  
Therefore, the aims of this project were: 
1) to estimate the onset of the retrotransposition events that originated the two human 
ATXN3 paralogues;  
2) to compare the rates of evolution and selective constrains underlying the three ATXN3 
paralogues throughout the primate lineage;  
3) to gain insight into the mechanisms that led to the human-specific (CAG)n expansion and 
tract configuration  of  ATXN3; and 
4) to investigate if the human ATXN3 paralogues are transcribed and, if so, their mRNA 
transcription pattern. 
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Chapter 2 
Material and methods  
To achieve the aims of this project, an evolutionary approach (Part 1) was firstly performed, 
followed by functional assays (Part 2).  We have done evolutionary studies to compare the rates 
of evolution and selective constrains among ATXN3, ATXN3L1 and ATXN3L2 genes, and to date 
the onset of the retrotransposition events. We started by aligning homologous sequences from 
several primate species (followed by more distant mammals) available in databases. Afterwards, 
we calculated genetic distances and determined both the origin of ATXN3 retrocopies and the 
underlying selective pressures throughout evolution. In Part 2, we started by comparing the Open 
Reading Frames (ORFs) among ataxin-3 paralogues. For ATXN3L1, which showed a conserved ORF, 
we assessed the mRNA expression pattern in different human tissues, by Reverse Transcriptase-
PCR (RT-PCR). The two approaches, Part 1 and Part 2, are described below in detail. As it was 
previously referred, ATXN3 paralogues, described as ATXN3L and LOC100132280, will be named 
as ataxin-3 like 1 (ATXN3L1) and ataxin-3 like 2 (ATXN3L2), respectively, for easier reading. 
Subjects 
We analysed a total of 49 healthy human subjects from European (n=6) and Asian (n=43) 
origins. DNA samples were available at our lab, previously coded to ensure confidentiality. 
Informed consent was provided by all individuals. 
As for non-human primate species, we analysed DNA samples from Pan troglodytes 
(chimpanzee) (n=2), Gorilla gorilla (gorilla) (n=3), Pongo abelii (orangutan) (n=2), Macaca mulatta 
(rhesus monkey) (n=5), Macaca fascicularis (cynomolgus monkey) (n=3), Callithrix jacchus 
(marmoset) (n=3) and Papio (baboon) (n=3). DNA was quantified with NanoDrop 
spectrophotometer (Thermo Scientific) to further make work aliquots with a DNA concentration 
of approximately 30 ng/µL.  
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Part 1 – Evolutionary approach  
Compilation and alignment of ATXN3L1 and ATXN3L2 sequences  
To study the origin of the retrotransposition events, we first needed to identify ATXN3 
paralogues in public databases. We started by searching for annotated ATXN3L1 and ATXN3L2 
orthologues in primates and other mammalian species. Sequences of ATXNL1 were available in 
Ensembl database (http://www.ensembl.org/) for Homo sapiens, Pan troglodytes, Pongo abelii, 
Macaca mulatta, Callithrix jacchus and Nomascus leucogenys. The sequence from human 
ATXN3L2, termed LOC100132280, was obtained from the National Center for Biotechnology 
Information (NCBI) database (http://www.ncbi.nlm.nih.gov/), but no other annotated orthologues 
were found in either Ensembl or NCBI Gene databases. Therefore, we performed BLAT and BLAST 
algorithms provided by University of California, Santa Cruz (UCSC) Genome Browser 
(http://genome.ucsc.edu/) and NCBI databases, respectively. This way, we obtained not yet 
annotated homologous sequences of ATXN3L2 in the genome of several primate species. 
Following the same strategy, we searched for additional ATXN3L1 sequences of primate species 
not retrieved from Ensemble. The same approach was also applied to search for ATXN3L1 and 
ATXN3L2 orthologues in other mammals; in this case, however, we used mostly the Trace 
Archives specialized search of BLAST algorithm (NCBI).  
 The alignment of the collected sequences (coding regions for ATXN3) was performed in 
Geneious Pro, 5.5.6 software and the homology (percentages of pairwise identity and identical 
sites) between sequences was obtained among paralogues of primate species. This allowed to 
discern whether two independent retrotransposition events occurred or, alternatively, one of the 
copies duplicated from the most ancient retrocopy. 
 Next, to identify the transcript(s) of the parental gene involved in the retrotransposition 
events, we aligned ATXN3L1 and ATXN3L2 with the 21 protein coding transcripts described for 
ATXN3. Transcripts were retrieved from Ensembl: ATXN3-001, ATXN3-003, ATXN3-004, ATXN3-
005, ATXN3-008, ATXN3-015, ATXN3-017, ATXN3-019, ATXN3-020, ATXN3-026, ATXN3-029, 
ATXN3-032, ATXN3-201, ATXN3-202, ATXN3-203, ATXN3-204, ATXN3-205, ATXN3-206, ATXN3-
207, ATXN3-208 and ATXN3-209. In humans, ATXN3-001 has been described as the most common 
transcript, followed by ATXN3-003, 004 and 005. 
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Phylogenetic trees and genetic distances   
 Based on the aligned sequences, we calculated genetic distances among orthologues and 
paralogues, and constructed phylogenetic trees for all species, by using the same software, 
Geneious Pro 5.5.6. To build the trees, we applied the Neighbor-Joining method and the Tamura-
Nei genetic distance model (chicken, Gallus gallus, was included as outgroup). This approach was 
performed to identify ATXN3L1 and ATXN3L2 orthologues. Since the Josephin domain is the most 
conserved region of ATXN3 and the (CAG)n region is usually a source of much variation, we 
assessed genetic distances and built phylogenetic trees for all three paralogues by using: 1) the 
entire sequences; 2) the sequences without the (CAG)n tract; and 3) the Josephin domain alone. 
Synteny of ATXN3, ATXN3L1 and ATXN3L2  
We analysed the genes flanking ATXN3, ATXN3L1 and ATXN3L2 in a region of, at least, 600000 
base pairs (bp) to elucidate if these regions were conserved along the primate lineage, confirming 
thus gene orthologies. This was performed by using NCBI Gene database, UCGC Genome Brower 
genomes and Ensembl Synteny analyses. If two flanking regions of a given gene have obvious 
collinear genomic features, they are syntenous. From this information, therefore, we can 
conclude that predicted orthologue genes having syntenous flanking regions have higher 
probability to be real orthologues. In addition, the same approach was applied to analyse 
sequences of non-primate mammals: their flanking regions were compared to those retrieved 
from primates in order to identify if they were ancestral retrocopies of ATXN3L1 and/or ATXN3L2, 
or alternatively, originated from independent retrotransposition events.  
dN/dS ratio (omega) calculations 
Evolutionary pressures on proteins can be quantified by the ratio of substitution rates at non-
synonymous and synonymous sites. We calculated dN/dS values (omega) of ATXN3 and ATXN3L1 
genes for different primate species, using the DnaSP v5 software. The dN value represents the 
rate of non-synonymous substitutions (nucleotide changes that result in amino acid alterations) 
per site, whereas dS is the rate of synonymous substitutions (silent alterations that do not change 
the amino acid residue). Thus, a dN/dS ratio (omega) is expected to exceed unity if substitutions 
are equally frequent at all three codon positions, indicating that no constrains have been 
underlying the gene. On the other hand, omega less than unity is expected if selection suppresses 
protein changes, suggesting that the gene function has been kept in check. These calculations 
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allowed us to compare the selective constrains that have been underlying ATXN3 paralogues in 
several lineages of primates. As ATXN3L2 presented a disrupted ORF, with the start codon 
mutated and several premature stop codons, we did not proceed with this calculation for this 
retrocopy.  
Primer design, DNA amplification and sequencing 
Based on the alignment of gene orthologues, primers were designed to specifically amplify 
ATXN3 (exonic regions), ATXN3L1 and ATXN3L2 in all primate species. Exons of ATXN3 annotated 
in NCBI database represent only those included in the most frequent transcript (11 exons). When 
analysing all ATXN3 protein coding transcripts represented in Ensembl data base, we retrieved 
other exons transcribed only in some transcripts (protein coding) and others only predicted to be 
transcribed. As reference, in this study, we used all ATXN3 exons annotated in Ensemble (21 in 
total), although for primer design, we selected only exons known to be transcribed. Figure 5 
summarizes this information. 
 
Figure 5  – Exons of the ATXN3 protein coding transcripts, according to Ensemble database. As some transcripts do not 
contain the entire exon sequence, percentages of coding sequences relatively to the total number of nucleotides of the exon 
were calculated and represented with different colors. Color legend is on the right side of the figure. 
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 For primate species that lacked the annotated sequence of one or more ATXN3 paralogues 
(namely chimp, gorilla, orangutan, gibbon, marmoset, cynomolgus monkey and baboon), we 
performed sequencing; the same PCR conditions and oligo pairs were used, regarding the 
sequence conservation of the selected primers for most of the primates. 
 For primer design, we selected the following criteria: 20 to 24 base pairs; a percentage of GC 
between 45 and 60%; and a melting temperature comprised between 56 and 64°C. The OligoCalc 
algorithm (http://www.basic.northwestern.edu/biotools/oligocalc.html) was used to calculate 
melting temperatures and GC percentages, as well as to predict the formation of hairpins and 
primer dimers. Primers predicted to form these structures were rejected. In addition, to avoid the 
formation of primer-dimmers, we used the AutoDimmer software to select primers with no such 
predicted structures. Finally, to analyze primers’ specificity for each species, we performed an 
UCSC Genome Browser In-Silico PCR (http://genome.ucsc.edu/cgi-bin/hgPcr?command=start). 
The list of selected primers is shown in Tables 1 and 2.  
Table 1 – Primers designed to specifically amplify ATXN3 exons. 
ATXN3 
Reaction Tannealing Exons Amplicon Primer sequence Species 
Pentaplex 57°C 
Part of 2 and 3 F2-R3 
F2  – GTGGTAAGCTGAGATTGCTCC             
R3 – CCAGCTGATGTGCAATTGAGG 
H. sapiens         
P. troglodytes  
G. gorilla            
P. abelii 
Part of 6 F6-R6 
F6  – CACAACTAACATAGCTACACTTCC    
R6 – AAGGCTACAGGGCAGATGCT 
9 F9-R9 
F9 – CCTGGCCAATGTGGCAAATG              
R9 – CACTGTCATCTAATGTGCCTG 
12 F12-R12 
F12 – GGTTGCAGTTATTACCAGTGC      
R12 – GAAATCTAAAGGGAAAGCCCAC 
16 F16-R16 
F16 – CTGATCCTAGGTCAGAAAACAGA 
R16 – GGCCGTGTGCTAGTATTTGTTG 
Hexaplex 60°C 
4 F4-R4 
F4 – GCACGCTAATGACAGTTTGTATCC         
R4 – GGTGAAACCCCACTATCTCTAC 
H. sapiens         
P. troglodytes  
G. gorilla            
P. abelii 
Part of 6 and 7 F6'-R7 
F6’– CAACAGTCCAGAGTATCAGAGGC    
R7 – GACAGGACCTCCCTTTGTTGCC 
11 F11-R11 
F11 – TCCAGTGTTCTGTGCTGCCTTTT  
R11 – AGTCGCCAACAACACAAGGACC 
17 F17-R17 
F17 – GGAAAGGCATCTCTGGGGAG     
R17 – GAAGTTTGACACGAGCCTGGAC 
18,19 and part of 20 F18-R20 
F18  – CCACTCCTGGCCATGATAGGT     
R20  – GAATGGTGAGCAGGCCTTACC 
21 F21-R21 
F21 –CTGGTGGCTATCTGGGATTAGGA   
R21 – GGACCCTATGCTGTAATCACACAG 
Duplex 1 64°C 
1 F1-R1 
F1 – CGTGTCCCCGGCGTTCACTC               
R1 – AGATCGGCATGGGGGCGACT                  
F3 – GCAAGAAGGCTCACTTTGTGCTC    
R3’ – CAAGGGTGGGGGTGGGGAAA 
H. sapiens         
P. troglodytes  
G. gorilla            
P. abelii 3 F3-R3' 
Duplex 2 64°C 
13 and 14 F13-R14 
F13 – ACGCCCAGCCAGAAGAGTAG           
R14 – CTCCTGACCTCAGGCAATCTG           
F20 – GGCCAGCCACCAGTTCAGGAG 
R20’ – TCCTCTCCTGCCTTGGTTTCCC 
H. sapiens         
P. troglodytes  
G. gorilla            
P. abelii Part of 20 F20-R20 
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Table 2 - Primers designed to specifically amplify ATXN3L1 and ATXN3L2 genes. 
* As the ATXN3L2 sequence of Callithrix jacchus differed more than 25% from the other sequences, different primers were 
designed for this species. 
We optimized polymerase chain reactions (PCRs) with the designed primers described above. 
PCRs were done in a final volume of 10 µL, with 1x of Taq polymerase 2x (MyTaq;  BIOLINE) and 
0.25 µM (in singleplex reactions) or 0.125 µM (in multiplex reactions) of each primer. PCR 
conditions are described in Figure 6.  
 
 
 
 
 
 
To confirm specificity of DNA amplification, PCR products were submitted to electrophoresis 
in a polyacrylamide gel prepared with 0.375M Tris/HCl gel buffer (pH=8.8). The gel was obtained 
by mixing 3 mL T9C5 (9% acrylamide, 5% N-N-metileno-bis-acrylamide), 170 µL of 1% ammonium 
persulfate and 7 µL of TEMED as catalysis agent. Glass supports, with one side covered by a 
hydrophilic gel-bond film, were used to obtain a 3 mm thick gel. After loading the samples in the 
ATXN3L1 and ATXN3L2 
 Reaction  Tannealing  Gene  Amplicon   Primer sequence  Species 
Singleplex 1 59°C ATXN3L1 L1F1-L1R1 
L1F1 – CTCTAACTAGGATACCAGCAAAG   
L1R1 – GGAAAAAGTTCTATGGCAAGAGC 
H. sapiens              
P. troglodytes        
G. gorilla               
P. abelii               
M. mulatta         
N. leucogenys      
C. jacchus 
Singleplex 2 57°C ATXN3L2 L2F1-L2R1 
L2F1 – CATTAACCAAAGAAAGTGGGATAC    
L2R1  – GGAATCCTATGCTGTAATCACAC 
H. sapiens              
P. troglodytes        
G. gorilla               
P. abelii               
M. mulatta         
N. leucogenys   
Singleplex 3 57°C ATXN3L2 cL2F1-cL2R2 
L2F1 – CATTAACCAAAGAAAGTGGGATAC    
L2R1  – GGAATCCTATGCTGTAATCACAC 
C. jacchus* 
Hold 3 
1x Hold 2 
zx 
Hold 1 
1x 
95°C 
15’ 
94°C 
1’30’’ 
30’’ 
Y’ 
72°C 
x°C 
10’ 
70°C 
Figure 6 – General PCR protocol with time (‘- minutes; ‘’ – seconds) and temperatures (°C) for the amplification of ATXN3, 
ATXN3L1 and ATXN3L2 loci. X, Y and Z vary according to the multiplex/singleplex reaction: X (annealing temperature) – 
described in Tables 1 and 2; Y (extension time) – 2 minutes for singleplex, and 1 minute for multiplexes; Z (number of cycles) - 
30 for ATXN3; 35 for ATXN3L1; and 40 for ATXN3L2. 
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gel, two paper strips soaked in buffer were used at both anode and cathode to allow the 
horizontal run. To monitor the process of electrophoresis, we added bromophenol blue dye to the 
anode strip. The electrophoretic system was submitted to refrigeration at 4°C, and to a voltage 
between 220 and 250 V. The gel was then submitted to silver staining. The coloration method 
comprised (1) a fixation step of the DNA, with 10% ethanol for 10 minutes followed by 1% nitric 
acid for 5 minutes; (2) two washes with deionized water, of about 20 seconds each; (3) a 
coloration step with 0,2% silver nitrate solution, for 20 minutes; (4) two washes again with 
deionized water, for 20 seconds each; and finally, (5) a revelation step of the DNA fragments with 
a solution of 0,28 M sodium carbonate and 0,02% formaldehyde. The revelation reaction was 
stopped with 10% acetic acid for approximately 30 seconds. The resulting gels were washed with 
water and dried at room temperature.  
After optimizing PCR reactions, we proceeded with sequencing. Products were first purified 
with ExoStar (GE Health Care), for 15 minutes, at 37°C, followed by 15 minutes at 80°C to 
inactivate the enzyme. ExoStar contains a mix of Alkaline Phosphatase and Exonuclease 1, 
formulated to remove unincorporated primers and nucleotides from de resulting PCR products.  
For sequencing procedures, we used Big Dye Terminator Cycle Sequencing Ready Reaction kit 
(Applied Biosystems) as mix containing normal deoxynucleotides, dye dideoxynucleotides, buffer 
and AmpliTaq DNA Polymerase. For each reaction of 5 µL, we combined 1 µl of Big Dye mix, 
sequencing buffer 2.5x, and 0.5 µM of primer with 2.5 µL of purified PCR product. Cycling 
conditions are described in Figure 7. 
 
 
 
 
 
Finally, sequencing products were purified using Sephadex columns, a cross-linked dextran-gel 
used to separate the low (unincorporated nucleotides and primers) from high molecular weight 
molecules of DNA (sequencing products); formamide was then added to the final product to 
increase the stability of single-stranded DNA for the capillary electrophoresis run in an ABI 3130 
Hold 3 
1x Hold 2 
35x 
Hold 1 
1x 
96°C 
2’ 
96°C 
5’’ 
15’’ 
2’ 
60°C 
55°C 
10’ 
60°C 
Figure 7 - General protocol with time (‘- minutes; ‘’ – seconds) and temperatures (°C) for 
sequencing ATXN3, ATXN3L1 and ATXN3L2 PCR products 
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Genetic Analyzer. Sequences were analysed with Sequencing Analysis v5.2 software (Applied 
Biosystems). 
Nucleotide diversity of human ATXN3 retrocopies 
To evaluate the nucleotide diversity underlying ATXN3L1 and ATXN3L2 human retrocopies, we 
aligned sequences obtained from the previous step and annotated all variations relative to the 
reference sequence.  We calculated frequencies of variants and predicted the alterations in the 
respective putative coding sequences. 
 (CAG)n tract analysis in ATXN3, ATXN3L1 and ATXN3L2   
We compared the (CAG)n tract configuration among the three paralogues for all species based 
on (1) sequences collected from NCBI, Ensembl and UCSC Genome browser, and (2) results 
obtained from sequencing (Pan troglodytes, Gorilla gorilla, Pongo abelii, Macaca mulatta, Macaca 
fascicularis and Papio). 
Part 2 – Functional approach 
ORF prediction for ATXN3L1 and ATXN3L2  
Since little was known regarding the functional relevance of ATXN3L1 and ATXN3L2, we 
started by predicting the respective ORFs. Predictions were performed by using NCBI Open 
Reading Frame Finder (ORF Finder - http://www.ncbi.nlm.nih.gov/projects/gorf/) graphical 
analysis tool.  
Conservation of the ATXN3L1 putative protein  
The expected protein coding sequence of ATXN3L1 was aligned and compared to the most 
common coding sequence of the parental gene, the ATXN3-001 transcript. The Josephin domain, 
UIMs and polyQ tract were annotated in sequences, as well as other important sites/amino acids 
such as the nuclear export signals NES77 and NES141, the nuclear localization signal NLS273, and 
the catalytic amino acid triad. With this comparative study, we were able to determine if ATXN3L1 
conserved the most important functional components of the parental protein and, thus, a 
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potential similar functional activity. As ATXNL2 presented premature stop codons and is unlikely 
to be translated, we did not proceed with further analysis in this retrocopy. 
mRNA expression of ATXN3L1 
To evaluate if ATXN3L1 is transcribed, primers were designed to specifically amplify ATXN3L1 
cDNA. The cDNA of 16 different human tissues was previously obtained by conversion from 
mRNA, using reverse transcriptase PCR (RT-PCR). Analysed tissues included: ovary, bladder, 
trachea, esophagus, thymus, thyroid, colon, kidney, skeletal muscle, testis, small intestine, heart, 
spleen, prostate, liver and brain. 
We started by aligning the ATXN3L1 sequence with the concatenated exons of parental 
ATXN3; this way, we annotated the exons’ limits of the parental gene in the retrocopy. Then, 
primers were designed in regions flanking the exon junctions of the corresponding ATXN3 exons. 
Primers are listed in Table 3. 
Table 3 - Primers designed to specifically amplify ATXN3L1 in human cDNA. 
 
PCR conditions were similar to those used for sequencing described above (Figure 1), using 
58°C as annealing temperature, 1 minute for extension time, and 35 cycles. To confirm 
amplification, we have done an electrophoresis run, followed by silver stained, as described 
above. The expected product sizes are approximately 110 bp for UTR-E2, 140 bp for E7-8, 130 bp 
for E8-9 and 110 bp for E10-11 amplicon. 
 
 
 
 
cDNA ATXN3L1 primers 
 Reactions  Tannealing (°C) ATXN3 exons Amplicon   Primer sequence  
ATXN3L1 
 cDNA 
58 
UTR, 1 and 2                   
7 and 8                              
8 and 9                                
10 and 11  
UTR-E2F - UTR-E2R                                    
E7-8F - E7-8R                                
E8-9F - E8-9R                              
E10-11F - E10-11R 
UTR-E2F - GCATACAACATCTTCCGGCATACC   
UTR-E2R - CAGACAGTGCTGAGCACACAGGA        
E7-8F - CAGTGTCGAAGAGATGGATAC              
E7-8R -  CCTCATCTTGGTCTGATGTTCCAGACT                              
E8-9F - GAACTAAGCCGCCAAGAAACC               
E8-9R -   GCAGGAGTTACACATGATGTCTTTGGA                            
E10-11F - GGGCCACAGTTCATACCTACAC       
E10-11R - TGTCGACAGCGGCCTGTACTG 
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Chapter 3 
Results  
Part 1 – Evolutionary history of ATXN3 paralogues  
1. Onset of ATXN3 retrocopies 
1.1. Identification of ATXN3L1 and ATXN3L2 orthologues in the primate lineage 
We retrieved the coding sequence of ATXN3 for several primates (Table 4). Although the size 
and location of the collected sequences varied among species, we found homogeneity on both 
parameters for great apes: humans, chimpanzees, gorillas and orangutans. Notably, when 
compared to the human sequence, differences were found in ATXN3 sequences of 1) gorilla, in 
which exon 2 is not annotated as being translated; 2) orangutang, which does not possess a 
complete annotated transcription for exon 2; and 3) tarsier, for which databases do not display 
the complete sequence.  
As for ATXN3 retrocopies, a high homology to the human ATXN3L1 and ATXN3L2 sequences 
was found in Pan troglodytes, Gorilla gorilla, Pongo abelii, Macaca mulatta, Callithrix jacchus, 
Nomascus leucogenys, Tarsius syrichta and Otolemur garnettii. Based on the percentages of 
homology to human retrocopy sequences, calculated through NCBI-BLAST analysis, we designated 
the collected sequences as ATXN3L1 or ATXN3L2 (Tables 5 and 6). Tarsier and bushbaby 
sequences (found to be aligned with the human ATXN3L1, by using the “comparative genomics” 
tool of Ensembl) presented a high divergence from both human ATXN3L1 and ATXN3L2. For this 
reason, the alignment performed by Ensembl did not give us a reliable hint on the origin of these 
copies in the tarsier and bushbaby species; we, thus, named them as “ATXN3L?” at this point of 
the project. One other sequence for tarsier was retrieved from trace archives specialized BLAST of 
NCBI (Table 7). No sequence homologies were found in other primate species with genomes 
included in trace archives, such as Pan paniscus (bonobo), Pongo pygmaeus (bornean orangutan), 
Lemur Catta (ring-tailed lemur), Aotus nancymaae (Nancy Ma's night monkey), Callicebus moloch 
(red-bellied Titi), Chlorocebus aethiops (grivet or green monkey), Hylobates concolor (black 
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crested gibbon),  Ateles geoffroyi (Geoffroy's spider monkey), and others. This might be partially 
explained by the fact that trace archives contain highly fragmented sequences and that these data 
files are not official entries of the GenBank database, thus, with no associated feature 
annotations.  
Additionally to the ATXN3L1 and ATXN3L2 sequences retrieved above, other less homologous 
sequences (displaying, even though, more than 80% sequence identity to human ATXN3 coding 
sequence) were found in Ensembl data base for Macaca mulatta and Callithrix jacchus (Table 7). 
These sequences, here classified also as ATXN3L?, were aligned with all ATXN3, ATXN3L1 and 
ATXN3L2 (Figure A1 of the Appendix section) to next calculate genetic distances among them in 
topic 1.3 of the Results section. 
 
Table 4 – ATXN3 genomic and coding sequences compiled for 9 primate species. a) Genomic location of Macaca mulatta 
ATXN3 was assessed through the UCSC Genome Browser; b) Incomplete annotated sequence. 
 
 
Table 5 – ATXN3L1 sequences compiled for 7 primate species.  
 
 
 
ATXN3        
Species Source Location 
Size of genomic/coding 
sequences (bp) 
Homo sapiens  Ensembl chr14: 92,524,896-92,572,965 48070/1113 
Pan troglodytes  Ensembl chr14: 91,609,895-91,656,494 46600/1086 
Gorilla gorilla Ensembl chr14: 73834975-73877125:-1 42151/937 
Pongo abelii Ensembl chr14: 93360787-93404545:-1 43759/996 
Nomascus leucogenys Ensembl GL397280.1: 29388208-29433598:-1 45391/1080 
Macaca mulatta Ensembl Scaffold 1099553000000: 10,051-45,764 (Chr7)a 35714/1059 
Callithrix jacchus Ensembl chr10: 117,483,688-117,689,710 206023/1101 
Otolemur garnettii Ensembl GL873539.1: 18068653-18100321:-1 31669/867b 
Tarsius syrichta Ensembl GeneScaffold_567: 5192-20314:-1 15123/1089 b 
ATXN3L1 
  Species  Source  Location  Size (bp) 
Homo sapiens  Ensembl chrX: 13336770-13338518:-1 1068 
Pan troglodytes  Ensembl chrX: 13251386-13252912:-1 1062 
Gorilla gorilla UCSC chrX: 13240248-13241315 1068 
Pongo abelii Ensembl chrX: 13230000-13231067:-1 1069 
Nomascus leucogenys Ensembl GL397281.1: 10,640,111-10,641,175 1065 
Macaca mulatta Ensembl chrX: 11,016,157-11,017,194 1065 
Callithrix jacchus Ensembl chrX: 11,295,476-13,523,142 1062 
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Table 6 - ATXN3L2 sequences compiled for 7 primate species, mainly by using BLAST and BLAT algorithms, from NCBI and UCSC 
Genome Browser, respectively.  
 
   
 
Next, to undoubtedly classify ATXN3L1 and ATXN3L2 orthologues in primates and distinguish 
them from other independent-origin copies, we started by assessing the synteny of all ATXN3, 
ATXN3L1 and ATXN3L2 (Table 8 – A, B and C). For Tarsius syrichta and Otolemur garnettii, this 
search over flanking regions was not possible in any database. To assess their origin, we 
compared genetic distances and constructed phylogenetic trees in the next topic (1.2 of the 
Results section).  
By analysing the synteny of ATXN3 genomic regions, we noticed that up and downstream 
genes were constant throughout the primate lineage. Upstream genes include, mainly, CPSF2 
(cleavage and polyadenylation specific factor 2) and NDUFB1 (NADH dehydrogenase 1 beta 
subcomplex), whereas downstream genes include TRIP11 (thyroid hormone receptor interactor 
11) and FBLN 5 (fibulin 5). The sodium/potassium/calcium exchanger gene was only detected 
upstream to ATXN3 of some primates (Homo sapiens, Pongo abelii and Otolemur garnetii); 
however, it may be also present in other species since some genes may have currently not been 
annotated for all species. The same applies to PTMAP7 (prothymosin, alpha pseudogene 7), only 
detected downstream to ATXN3 in humans and chimps.  
ATXN3L2 
   Species  Source  Location  Size (bp) 
Homo sapiens  NCBI (Gene ID: 100132280) 8q23.2   1109 
Pan troglodytes  BLAST/BLAT search chr8: 109011629-109012743 1115 
Gorilla gorilla BLAST/BLAT search chr8: 109925669-109926225 1084 
Pongo abelii BLAST/BLAT search chr8: 117579303-117579866 1075 
Nomascus leucogenys BLAST/BLAT search GL397267:24598565-24599123 1075 
Macaca mulatta BLAST/BLAT search chr8:112963801-112964361 1079 
Callithrix jacchus BLAST/BLAT search chr19:6218140-6218664 1056 
 
ATXN3L?   
Species Source Location/Accession 
Callithrix jacchus Ensembl chr20: 28,630,500-28,631,553 
Macaca mulata Ensembl chr11: 122178105-122178311 
Tarsius syrichta (seq1) Ensembl - Comp. genomics Unknown 
Tarsius syrichta (seq2) BLAST - Trace Archives Unknown 
Otoloemur garnettii Ensembl - Comp. genomics Unknown 
  
Table 7 - Additional ATXN3 paralogues found in primates. 
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When we analysed the synteny of ATXN3L1, we have found a conserved upstream region 
across the 7 primates, which included TCEANC (transcription elongation factor A N-terminal and 
central domain containing) and EGFL6 (epidermal growth factor-like protein 6) genes. In addition, 
downstream sequences contained typically two or three of the following genes:  FAM9C (family 
with sequence similarity 9, member C), TMSB4X (thymosin beta 4, X-linked) and TLR8 (toll receptor 
9 precursor, CD289 antigen).  
As for ATXN3L2, the majority of primate species presented KCNV1 (potassium channel, 
subfamily V, member 1) in the 5’ flanking region and CSMD3 (CUB and Sushi multiple domains 3) 
downstream. Human 3’ genes were distinct from all other primates: two pseudogenes were  
present, one of them, with the respective parental gene located upstream of ATXN3 in humans 
(NADH dehydrogenase 1 beta subcomplex pseudogene). Upstream regions are, however, 
conserved, supporting this retrocopy is the human ATXN2 orthologue. Therefore, from this 
analysis, we confirmed that the majority of collected sequences had been correctly classified 
based on sequence homology. In the case of the marmoset retrocopy, however, previously 
classified as ATXN3L2, synteny did not favour our first hypothesis of a common origin shared with 
other ATXN3L2 orthologues. We, therefore, reclassified this Callithrix jacchus sequence as 
ATXN3L?2 and performed additional analyses to identify its origin (ATXN3L?1 denotes the first 
detected independent-origin retrocopy for Callithrix jacchus). 
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Table 8 - Synteny of ATXN3 (A), ATXN3L1 (B) and ATXN3L2 (C) through evidence based on collinearity of genes in primates. Two or three genes were retrieved within an interval of 600000 bp, except 
those marked with an asterisk (*) which were found outside this interval.  a, b and c next to the species name represent the source of the information: Ensembl, NCBI and UCSC Genome Browser, 
respectively. When information for a specific gene or location was retrieved from a source different from the indicated at species name, a, b or c specify the source.  
 
A - ATXN3       
Species Flanking 5'   Gene location Flanking 3' 
Homo sapiensa  
NM_153648.3 (sodium/potassium/calcium exchanger 4 isoform 3) 
 CPSF2 (cleavage and polyadenylation specific factor 2)                                                                                 
NDUFB1 (NADH dehydrogenase (ubiquinone) 1 beta subcomplex)                                                   
Chr.14q32.1 
 PTMAP7 (prothymosin, alpha pseudogene 7)
b
                                                                               
TRPIP11 (thyroid hormone receptor interactor 11)                                                                                          
FBLN5 (fibulin 5)                                                                                                  
Pan troglodytes
a 
 
 CPSF2 (cleavage and polyadenylation specific factor 2)                                                                              
NDUFB1 (NADH dehydrogenase (ubiquinone) 1 beta subcomplex)                                                   
Chr.14: 91,609,895-91,656,494 
 LOC100614355 (prothymosin alpha-like)b                                                                            
TRPIP11 (thyroid hormone receptor interactor 11)                                                                                         
FBLN 5 (fibulin 5)        
Gorilla gorilla
a
  
 CPSF2 (cleavage and polyadenylation specific factor 2)                                                                                 
NDUFB1 (NADH dehydrogenase (ubiquinone) 1 beta subcomplex)                                                   
Chr.14: 73,834,975-73,877,125 
 TRIP11 (thyroid hormone receptor interactor 11)                                                                                                            
FBLN 5 (fibulin 5)                                                
Pongo abeliia 
LOC100443929 (cleavage and polyadenylation specific factor 2)b 
NDUFB1 (NADH dehydrogenase (ubiquinone) 1 beta subcomplex)                                                                                              
LOC100446268 (Retinal Na+/ Ca2+/K+ Exchanger) 
Chr.14: 93,360,787-93,404,545
  LOC100441607 (thyroid hormone receptor interactor 11)                                                                                      
FBLN 5 (fibulin 5)                   
Macaca mulatta ? 
Chr.7 b                                                     
(Scaffold 1099553000000: 10,051-45,764)a 
  LOC100423180 (uncharacterized)
b
  
Callithrix 
jacchusb 
 CPSF2 (cleavage and polyadenylation specific factor 2)                                           
LOC100414432 (uncharacterized)    
Chr.10: 117,483,688-117,689,710a 
TRPIP11 (thyroid hormone receptor interactor 11)                                                                               
FBLN 5 (fibulin 5)a                                                                                                
Nomascus 
leucogenysa  
 CPSF2 (cleavage and polyadenylation specific factor 2)                                                                                 
NDUFB1 (NADH dehydrogenase (ubiquinone) 1 beta subcomplex)                                                   
(GL397280.1: 29,388,208-29,433,598) 
 TRIP11 (thyroid hormone receptor interactor 11)                                                                                                            
FBLN 5 (fibulin 5)                                                
Otolemur 
gametiia 
SLC24A4 (Solute carrier family 24 (sodium/potassium/calcium 
exchanger), member 4)                                                                                                                                  
ENSOGAG00000032385 (cleavage and polyadenylation specific 
factor 2)  
(GL873539.1: 18,068,653-18,100,321) 
 TRIP11 (thyroid hormone receptor interactor 11)                                                                                                            
FBLN 5 (fibulin 5)                                                
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B - ATXN3L1 
 
  
  
 
 
 
Species Flanking 5'    Sequence location Flanking 3' 
Homo sapiensa  
 TCEANC (transcription elongation factor A (SII) N-terminal and central domain containing)                                    
       GPX1P1 (glutathione peroxidase pseudogene 1 provided)b                                                                            
EGFL6 (epidermal growth factor-like protein 6)     
Xp.22.2 
FAM9C (family with sequence similarity 9, member C)                                          
TMSB4X (thymosin beta 4, X-linked)                                                                                                                                                                                  
TLR8 (Toll Receptor 9 Precursor,  CD289 Antigen) 
Pan troglodytes
a
 
 TCEANC (transcription elongation factor A (SII) N-terminal and central domain containing)                                 
    EGFL6 (epidermal growth factor-like protein 6)                                
ChrX: 13,251,386-13,252,912 
LOC735851 (family with sequence similarity 9, member C)                                                                                                 
LOC465493 (uncharacterized)                                                                                                                            
B3Y655_PANTR  (Toll Receptor 9 Precursor,  CD289 Antigen) 
Gorilla gorillac  
 TCEANC (transcription elongation factor A (SII) N-terminal and central domain containing)                                   
  EGFL6 (epidermal growth factor-like protein 6)                                                                                 
ChrX: 13240776-13241315 
FAM9C (family with sequence similarity 9, member C)                                                             
TMSB4X (thymosin beta 4, X-linked)            
Pongo abeliia 
TCEANC (transcription elongation factor A (SII) N-terminal and central domain containing                                               
  LOC100461104  (uncharacterized)                                                                                                                  
LOC100460736 (epidermal growth factor-like protein 6)                                     
ChrX: 13,230,000-13,231,067 
LOC100452699 (protein FAM9C-like)                                                                                               
TYB4_PONAB  (thymosin beta 4, X-linked)                                                                                                        
TLR8 (Toll Receptor 9 Precursor,  CD289 Antigen) 
Macaca 
mulatta
c
 
 LOC711362  (transcription elongation factor A (SII) N-terminal and central domain 
containing)                                  
   EGFL6 (epidermal growth factor-like protein 6)                                
ChrX: 11,016,157-11,017,194 
LOC711039  (family with sequence similarity 9, member C)                                                
LOC710959  (Unknown)                                                                                                           
ENSMMUG00000032533 (Unknown)                                                                                                          
ENSMMUG00000032532 (Unknown)                                                                        
B6CK00_MACMU (Toll Receptor 9 Precursor,  CD289 Antigen) 
Callithrix 
jacchusa 
 LOC100388682  (transcription elongation factor A (SII) N-terminal and central domain 
containing)                          
           EGFL6 (epidermal growth factor-like protein 6)                                
ChrX: 11,295,476-13,523,142 
          LOC100415563  (thymosin beta 4, X-linked)                                                                                  
TLR8 (Toll Receptor 9 Precursor,  CD289 Antigen) 
Nomascus 
leucogenysa 
 TCEANC (transcription elongation factor A (SII) N-terminal and central domain containing)                                
     EGFL6 (epidermal growth factor-like protein 6)                                
  GL397281.1: 10,640,111-10,641,175 
FAM9C (family with sequence similarity 9, member C)                                                                 
TLR8 (Toll Receptor 9 Precursor,  CD289 Antigen) 
C - ATXN3L2 
   Species Flanking 5'  Sequence  location Flanking 3' 
Homo sapiensb  
KCNV1 (potassium channel, subfamily V, member 1)c                                                                                               
RPSAP48 (ribosomal protein SA pseudogene 48)* 
Chr8q23.2                          
(Chr8: 111567628-111568736) 
LOC100129370 (NADH dehydrogenase (ubiquinone) 1 beta subcomplex) - pseudogene 
EEF1A1P37 (eukaryotic translation elongation factor 1 alpha 1 pseudogene 37) 
Pan troglodytes  unknown   unknown 
Gorilla gorillac  
KCNV1 (potassium channel, subfamily V, member 1)                                                    
ENSGGOG00000022520 (40S Ribosomal) 
Chr8: 109925669-109926225 
ENSGGOG00000023880 (Unknown)                                                                                                                          
ENSGGOG00000035637 (U4 spliceosomal RNA)*                                                                                               
CSMD3 (CUB and Sushi multiple domains 3)*        
Pongo abeliic KCNV1_PONAB  (potassium channel, subfamily V, member 1)*                                      Chr8: 117579303-117579866                           CSMD3 (CUB and Sushi multiple domains 3)*        
Nomascus 
leucogenysc 
ENSNLEG00000024811 (U2 spliceosomal RNA)*                                                                                                   
KCNV1 (potassium channel, subfamily V, member 1)                                          
GL397267:24598565-24599123 
7SK (7SK RNA)                                                                                                                                
ENSNLEG00000022484 (U4 spliceosomal RNA)*                                                                                      
CSMD3 (CUB and Sushi multiple domains 3)*                   
Macaca mulattac 
ENSMMUG00000034903 (U2 spliceosomal RNA)                                                                                              
KCNV1 (potassium channel, subfamily V, member 1)                                       
Chr8:112963801-112964361 
LOC700556 (unknown)                                                                                                                       
LOC699756 (Nucleophosmin)                                                                                                                       
CSMD3 (CUB and Sushi multiple domains 3)* 
Callithrix 
jacchusc 
 5S_rRNA  (5S ribosomal RNA)                                                                                                 
LOC100389980  (Lysophospholipase 1)* 
Chr19: 6218140-6218664 
U3 (Small nucleolar RNA U3)                                                                                                                                 
C1orf143 (Unknown)                                                                                                                             
TGFB2 (Transforming Growth Factor Beta 1 Precursor) 
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1.2. Phylogeny of ATXN3 paralogues in primates 
To assess the phylogenetic relationships of ATXN3 paralogues identified in primates, we 
calculated the genetic distances among them (Table A1 of the appendix section). Based on these 
distances, a phylogenetic tree was constructed (Figure 8).  Although we could not reproduce the 
phylogenetic tree of species for each one of the paralogues, we could observe that ATXN3L1 and 
ATXN3L2 orthologues clustered to each other, confirming their conservation along the primate 
lineage. 
 
 
 
 
 
Marmoset ATXN3L?2 was shown to be similar to its ATXN3 coding sequence by sharing a 
recent node on the phylogenetic tree. This fact confirmed our reclassification of marmoset 
ATXN3L2 into ATXN3L?2 in the previous topic. 
ATXN3L?1 sequence of Tarsius syrichta was found to cluster next to ATXN3L1 orthologues and 
to share more similarity with these orthologues than with the parental or ATXN3L2 gene; for this 
reason, we reclassified it as ATXN3L1. On the other hand, the other Tarsier sequence, ATXN3L?2, 
shared a more recent ancestor with its parental sequence; therefore, its classification as ATXN3L? 
was maintained. As for Otolemur garnettii, ATXN3L? sequence did not seem to be orthologue of 
Figure 8 – Phylogenetic tree of ATXN3, ATXN3L1 and ATXN3L2 for primates, based on the genetic distances 
presented on Table A1 of the Appendix section. Gallus gallus was used as outgroup. 
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ATXN3L1 or ATXN3L2; instead, and as it  displayed also less genetic distance to its parental gene, 
ATXN3L? classification was maintained.  
The obtained phylogenetic tree was compared to others built based on ATXN3, ATXN3L1 and 
ATXN3L2 sequences (1) without the (CAG)n tract, and (2) containing the Josephin domain alone 
(Figures A2 and A3 of the Appendix section). No differences were found on the main clusters and 
nodes previously analysed to identify the origin of ATXN3L1 and ATXN3L2.  
After identifying ATXN3L1 and ATXN3L2 orthologues in primates, we wanted to gain insight 
into the events underlying their birth, namely the gene source. We, thus, calculated percentages 
of pairwise identities and identical sites by using aligned sequences of primates in which both 
retrocopies had previously been identified (Table 9). 
Table 9 - Pairwise identities and identical sites between ATXN3 paralogues of several primate species. The coding sequence of 
the parental gene and the corresponding aligned sequences of ATXN3L1 and ATXN3L2 were used in these calculations. A single 
value is shown when both percentages are identical.  
 
Pairwise identity (%)/identical sites (%) 
 
H. sapiens P. troglodytes G. gorilla P. abelii N. leucogenys M. mulatta 
ATXN3 vs 
ATXN3L1 
77.8 78.2 75.6/79.2 77.7/79.6 76.5 80.0/80.5 
ATXN3 vs 
ATXN3L2 
83.5 83.4 78.1/81.3 80.9/82.5 80.7 80.5/80.9 
ATXN3L1 vs 
ATXN3L2 
71.1 69.8 74.1 70.7/70.8 73.0 71.2 
 
A common pattern was observed for all species considered in this analysis: ATXN3L2 
presented a higher sequence identity to the ATXN3 coding sequence than ATXN3L1. In addition, 
both ATXN3L1 and ATXN3L2 shared a higher sequence identity to the parental gene than between 
them, suggesting that two independent events of retrotransposition have occurred, instead of 
one event followed by duplication.  
1.3. Identification of ATXN3 retrocopies in other mammals 
 After clarifying the origin of ATXN3 retrocopies in primates, we performed similar analyses for 
non-primate mammals to estimate the onset of the two most ancient retrotransposition events. 
Sequences homologous to ATXN3L1 and ATXN3L2 were obtained for Pteropus vampyrus 
(macrobat), Cavia Porcellus (guinea pig), Oryctolagus cuniculus (rabbit), Canis familiaris (dog), 
Cloloepus hoffmanni (sloth), Bos taurus (cow) and Monodelphis domestica (opossum). As none of 
these sequences was assigned as ATXN3L1 or ATXN3L2, we named them as ATXN3L?. Table 10 
resumes the main features of these sequences.  
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Table 10 – Additional ATXN3 paralogues found in 7 non-primate mammals. 
ATXN3L? 
  Species  Source  Location/Accession 
Pteropus vampyrus (seq1) BLAST - Trace Archives  gnl | ti:1371399947 
Pteropus vampyrus (seq2) BLAST - Trace Archives  gnl | ti:1328204199 
Cavia porcellus  BLAST - Trace Archives  scaffold_33: 11,426,907-11,427,913 
Oryctolagus cuniculus BLAST - Trace Archives  gnl | ti:1979192258 
Canis familiaris (seq1) Ensembl chr3: 10550724-10551819 
Canis familiaris (seq2) BLAST  NW_003726057.1 (chr5) 
Cloloepus hoffmanni (seq1) BLAST - Trace Archives  gnl | ti:1361780914 
Cloloepus hoffmanni (seq2) BLAST - Trace Archives  gnl | ti:1314261250 
Bos taurus (seq1) BLAST chr8: 63086126-63086972 
Bos taurus (seq2) BLAST chr10: 8893215-8893754 
Bos taurus (seq3) BLAST chr4: 3842581-3843107 
Monodelphis domestica  BLAST chr5: 24707322-24707854 
 
For the majority of the copies, here named ATXN3L?, size and location were not 
homogeneous among them. As for their syntenies, we could not determine chromosomal location 
in cases where searches were done in the trace archives of NCBI since only scaffolds were 
available (Pteropus vampyrus, Oryctolagus cuniculus and Choloepus hoffmanni). For species 
annotated in the UCSC Genome Browser, however, sequences were localized through BLAT 
algorithm to obtain the chromosomal region and further analysed for the respective neighbouring 
genes. Therefore, in addition to the previous referred ATXN3L? of rhesus monkey and marmoset, 
synteny was analysed for dog, guinea pig, cow and opossum retrocopies (Table 11). None of these 
copies shared any flanking genes with ATXN3, ATXN3L1 or ATXN3L2; instead, they differed also 
from each other. This data suggested that ATXN3L? sequences found in these mammalian species 
are in fact independent-origin rectrocopies of ATXN3, and that none of the non-primate mammal 
sequences is orthologue of ATXN3L1 or ATXN3L2. 
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Table 11 - Synteny of ATXN3L? copies through evidence based on collinearity of genes in non-primate mammals. Two or three genes were retrieved within an interval of 600000 bp, except those 
marked with an asterisk (*) which were found outside this interval.  a, b and c next to the species name represent the source of the information: Ensembl, NCBI and UCSC Genome Browser, respectively. 
When information for a specific gene or location was retrieved from a source different from the indicated at species name, a, b or c specify the source. 
 
 
 
 
 ATXN3L? 
    
Organism Flanking 5'  Sequence location Flanking 3' 
Human homologues of 
flanking genes
a
 
Callithrix 
jacchus
a
 
FA2H (fatty acid 2-hydroxylase)                                                                                                                                
MLKL (mixed lineage kinase domain-like) 
Chr20: 28,630,500-28,631,553 
WDR59 (WD Repeat containing 59)                                                                         
ENSCJAG00000014388 (Class I antigen) 
Chr16 
Macaca 
mulata
a
 
 P2RX7 (P2X Purinoceptor 7)                                                                                      
ENSMMUG00000031514 (Unknown) 
Chr11: 122178105-122178311 
SNORA70 (Small nucleolar RNA SNORA70)                                                                                
OASL (2'-5'-oligoadenylate synthetase-like)                                                                          
LOC701243 (Hepatocyte nuclear factor 1 alpha)  
Chr12
Canis 
familiaris
a
 
NUDT12 (Peroxisomal NADH pyrophosphatase)                                                                                                   
GIN1 (Gypsy Retrotransposon Integrase 1)                                                                                                                              
ENSCAFG00000024608 (Unknown)  
Chr3: 10550724-10551819 
ENSCAFG00000002024  (Heterogeneous Nuclear 
Ribonucleoprotein)                                      
 CDH1 (chromodomain helicase DNA binding protein 1) 
Chr5 
Cavia 
porcellus
c
 
ENSCPOG00000026477 (miRNA) 
    ENSCPOG00000016622 (5S_rRNA)                    
scaffold_33: 11,426,907-11,427,913 
ENSCPOG00000021308 (Scavenger Receptor Cystein Rich 
Type 1 M130 Precursor)                                 
ENSCPOG00000009339 (Unknown)* 
Unknown 
Organism Flank Sequence location Flank 
Human homologues of 
flanking genesa 
Canis 
familiarisc 
ELAC2 (ElaC homolog 2 - Zinc phosphodiesterase)*                                                                  
5S_rRNA  (5S ribosomal RNA)                                                                                   
ENSCAFG00000017903 (Heparan sulfate glucosamine 3-O-
sulfotransferase) 
Chr5: 40677963-40679029 
COX10 (COX10 homolog, cytochrome c oxidase assembly 
protein)                                                        
ENSCAFG00000017893 (Heparan sulfate glucosamine 3-O-
sulfotransferase) 
Chr17 
Bos taurusc  
C9orf174 - Chromosome 9 open reading frame 174 
(uncharacterized)                                                           
hypothetical protein LOC507550 (uncharacterized)  
Chr8: 63086126-63086972 
TDRD7_BOVIN  (Tudor domain-containing protein 7)                                                                                   
TMOD1_BOVIN (Tropomodulin-1)  
Chr9 
Bos taurusc  SNORA31 (small nucleolar RNA, H/ACA box 31) Chr4: 3842581-3843107 
A0JNG1 (Cordon Bleu Gene)                                                                                                                    
Q6U8D5_Bovin (Growth Factor Receptor Bound Adapter) 
Chr7 
Bos taurus
c
 
OTP (Orthopedia Homeobox)                                                                                                                                    
TBCA (Tubulin-specific chaperone A) 
Chr10: 8893215-8893754 
AP3B1 (AP-3 complex subunit beta-1)                                                                                              
Q3T0D2_Bovin (Secretory Carrier-Associated Membrane 
Protein 1) 
Chr5 
Monodelphis 
domesticac  
C4orf37 (Chromosome 4 open reading frame 379                                                                                                                       
PPM1K (protein Phosphatase, Mg2+/Mn2+ dependent, 1K)* 
Chr5:24707322-24707854 XM_001376187.1 (Casein Kinase I)* Chr4 
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In order to confirm the origin of ATXN3L? copies, sequences were aligned with the  coding  
regions of the respective parental gene, as well as with paralogue sequences previously identified 
for primates. From this overall alignment (Figure A1 of Appendix section), we calculated genetic 
distances (Table A4 of the Apendix section) and constructed a phylogenetic tree (Figure 9). Results 
showed all ATXN3L? sequences more similar to the respective parental genes than to primate 
ATXN3L1 or ATXN3L2 sequences. Indeed, they seemed to have originated independently and 
more recently after species divergence, instead of sharing common ancestral origins. In addition, 
the extra paralogue sequences found for M. mulatta (ATXN3L?) and C. jacchus (ATXN3L?1 and 
ATXN3L?2) also showed a most common recent ancestor with their parental sequences than with 
the other paralogues. This suggests that all sequences classified as ATXN3L?resulted, most likely, 
from additional retrotransposition events originated, more recently, from the respective parental 
genes.  
 
Figure 9 - Phylogenetic tree for ATXN3, ATXN3L1, ATXN3L2 and ATXN3L? retrocopies of mammals, based on the genetic 
distances represented on table A4 of the Appendix section. Gallus gallus was used as outgroup. 
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To confirm these results, we constructed phylogenetic trees of these three genes for all 
mammalian species (1) without the (CAG)n tract (usually a source of much variation), and (2) for 
the high conserved  Josephin domain alone (Figures A4 and A5). For the first, a similar tree was 
obtained, whereas the phylogenetic tree based exclusively on the sequence that encodes the 
Josephin domain (in ATXN3 and homologous sequences in its paralogues), has shown ATXN3L1 
genetically closer to the parental ATXN3 than ATXN3L2, suggesting that both have very similar 
Josephin domains, with most of the variation accumulated in the unstructured C-terminal. 
Finally, after performing all previous studies, we were able to estimate the time for the origin 
of ATXN3 paralogues (Figure 10), based on the tree of species and respective divergence times, in 
Figure A6 of the appendix section.    
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Figure 10 – Phylogenetic tree of primates. The presence of ATXN3L1 and ATXN3L2 is marked in each species 
with a red star and a blue circle, respectively. For ATXN3L1, the absence of the red star in Haplorrhines may be 
explained by incomplete gene annotation in databases. The same applies to blue circles marking ATXN3L2 in 
Catarrhines (adapted from http://whozoo.org/mammals/Primates/primatephylogeny.htm). 
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ATXN3L1 is present in the entire clade of Haplorrhines but absent in Strepsirrhines, indicating 
that the retrotransposition event on its origin occurred about 63 million years ago (MYA). As for 
ATXN3L2, since orthologues are present in the entire clade of Catarrhines but absent in 
Platyrrhines, the retrotransposition event is likely to have occurred about 35 MY ago.79 
2. ATXN3 transcripts involved in the retrotransposition events 
The alignment of ATXN3L1 and ATXN3L2 with the 21 human protein coding transcripts 
annotated in Ensembl has shown both paralogues more similar to ATXN3-001 than to any other 
transcript. Based on these results, both events of retrotransposition on the origin of ATXN3L1 and 
ATXN3L2 seemed to have involved this transcript, since they all share exons 1, 3 (part), 4 (part), 6 
(part), 7, 9, 11, 12, 13 (part), 20 (part) and 21 (based on Ensembl exon classification).  
3. Selective signatures underlying ATXN3L1 and ATXN3L2 
Evolutionary pressures on proteins were quantified by calculating the omega ratio, or the 
ratio of substitution rates at non-synonymous and synonymous sites, for ATXN3 and ATXN3L1 
genes, for different primate species (Table 12). 
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Omega values were always less than unity, for both ATXN3 and ATXN3L1 in all species 
comparisons. However, the rate of variance of these values were higher in the parental gene 
(from approximately 0.06 to 0.80) than in the ATXN3L1 paralogue, which showed less different 
values (mainly varying from 0.10 to 0.50). The fact that parental genes presented higher variance 
can be partly explained by the sequence differences found in gorilla, orangutan and tarsier. Still, 
as omega is less than unity in all calculations, our results suggested that selective constrains are 
suppressing protein changes, indicating that, as ATXN3, also the function of ATXN3L1 has been 
kept in check. 
Table 12 – dN/dS (omega) ratio calculations for ATXN3 and ATXN3L1, to illustrate the 
selective signatures underlying their evolution. 
dN dS ω dN dS ω
Hsap Ptro 0,0026 0,0094 0,2766 0,0291 0,0549 0,5301
Hsap Ggor 0,1146 0,1613 0,7105 0,0100 0,0246 0,4065
Hsap Pabe 0,0026 0,0190 0,1368 0,0163 0,0601 0,2712
Hsap Nleu 0,0051 0,0287 0,1777 0,0252 0,0979 0,2574
Hsap Mmul 0,0051 0,0686 0,0743 0,0323 0,2266 0,1425
Hsap Cjac 0,0129 0,1004 0,1285 0,1431 0,3902 0,3667
Hsap Tsyr 0,6000 0,8995 0,6670 0,2099 0,5639 0,3722
Ptro Ggor 0,1175 0,1500 0,7833 0,0304 0,0396 0,7677
Ptro Pabe 0,0051 0,0094 0,5426 0,0389 0,0730 0,5329
Ptro Nleu 0,0077 0,0191 0,4031 0,0421 0,1142 0,3687
Ptro Mmul 0,0077 0,0585 0,1316 0,0507 0,2388 0,2123
Ptro Cjac 0,0103 0,0900 0,1144 0,1605 0,4522 0,3549
Ptro Tsyr 0,6270 0,8730 0,7182 0,2335 0,5919 0,3945
Ggor Pabe 0,1146 0,1613 0,7105 0,0163 0,0345 0,4725
Ggor Nleu 0,1160 0,1678 0,6913 0,0233 0,6830 0,0341
Ggor Mmul 0,1190 0,1792 0,6641 0,0278 0,1919 0,1449
Ggor Cjac 0,1174 0,2500 0,4696 0,1378 0,3792 0,3634
Ggor Tsyr 0,1414 1,1120 0,1272 0,2022 0,5319 0,3801
Pabe Nleu 0,0026 0,0287 0,0906 0,0291 0,0867 0,3356
Pabe Mmul 0,0026 0,0483 0,0538 0,0375 0,1940 0,1933
Pabe Cjac 0,0103 0,1004 0,1026 0,1501 0,3617 0,4150
Pabe Tsyr 0,0572 0,8694 0,0658 0,2183 0,5221 0,4181
Nleu Mmul 0,0051 0,0792 0,0644 0,0355 0,1980 0,1793
Nleu Cjac 0,0129 0,0900 0,1433 0,1398 0,3840 0,3641
Nleu Tsyr 0,0572 0,8745 0,0654 0,2126 0,5783 0,3676
Mmul Cjac 0,0129 0,1561 0,0826 0,1334 0,4354 0,3064
Mmul Tsyr 0,0614 0,7724 0,0795 0,1979 0,7145 0,2770
Cjac Tsyr 0,0627 0,9714 0,0645 0,2529 0,7266 0,3481
ATXN3 ATXN3L1
vs.
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Variation ID Base position
Number of 
chromosomes 
analysed 
Ancestral 
allele 
Base change
Absolute 
frequencies 
Relative 
frequencies 
Annotated 
frequencies
Amino acid 
change
rs17847278 160 (Intron 4) 20 G A/G 7/13 0.35/0.65 0.29/0.71 NA
rs1997920 194 (Exon 6) 48 T T/C 24/24 0.50/0.50 0.31/0.69 NA
rs1997919 340 (Exon 6) 42 G G/A 22/20 0.52/0.48 0.69/0.31 NA
rs1997918 417 (Exon 6) 42 A G/A 3/39 0.07/0.93 0.01/0.99 NA
rs1997917 434 (Exon 6) 44 G G/A 23/21 0.48/0.52 0.27/0.73 NA
rs4904834 524 (Intron6) 42 C* G/C 24/18 0.57/0.53 0.45/0.55 NA
rs8003520 1081 (Intron 8) 16 G G/A 3/13 0.19/0.81 0.30/0.70 NA
rs12590497 129 (Intron 10) 16 T G/T 10/6 0.63/0.37 0.68/0.32 NA
rs16999141 17 (Exon 11) 12 T C/T 6/6 0.50/0.50 0.47/0.53 V/V
rs1048755 26 (Exon 12) 16 G A/G 6/10 0.31/0.69 0.26/0.74 M/V
rs761553 1220 (Intron 12) 16 C G/C 6/10 0.38/0.62 0.68/0.32 NA
rs761552 31 (Exon 14) 14 C T/C 7/7 0.50/0.50 0.32/0.68 M/Ta
rs761551 24 (Intron14) 14 C A/C 7/7 0.50/0.50 0.31/0.69 NA
rs10467858 127 (Intron 17) 12 G* A/G 6/6 0.50/0.50 0.27/0.73 NA
rs7158733 201 (Exon20) 18 C* C/A 13/5 0.72/0.28 0.68/0.32 Y/Stopb
rs3092822 261 (Exon 20) 22 A* A/C 14/8 0.64/0.36 0.68/0.32 E/Db
c.2926A>G 319 (Exon20) 22 A* A/G 8/14 0.36/0.64 undetermined K/E
b
c.939G>A 939 38 G* A/G 2/36 0.05/0.95 undetermined R/R
c.995A>G 995 37 A* A/G 6/31 0.16/0.84 undetermined D/G
c.230T>C 230 68 T* C/T 2/66 0.03/0.97 undetermined NA
c.398G>A 398 76 G* A/G 1/74 0.01/0.99 undetermined NA
c.752G>A 752 64 G* A/G 3/61 0.04/0.96 undetermined NA
ATXN3L2                
(Chr. 8)
ATXN3                    
(Chr. 14)
ATXN3L1                
(Chr. X)
4. Nucleotide diversity of ATXN3L1 and ATXN3L2 
We have assessed genetic variation of all ATXN3 paralogues by sequencing a total of 49 
human DNA samples (Table 13). For ATXN3, we have found a total of seventeen variations, mostly 
in intronic regions (or in regions that can be transcribed only by less common alternative splicing), 
according to the Ensemble exon/intron sequence annotations. This is consistent with the fact that 
transcriptionally active regions of the genome are more prone to be conserved. In exonic regions, 
we have found six variations: five non-synonymous and one synonymous coding. From these six 
variations, however, only two (one synonymous and one non-synonymous) were common to all 
transcripts; the other four were present only in three or fewer transcripts, none of them on the 
four most common ATXN3 transcripts.  
 
For ATXN3L1, only two variations were detected, both near the end of the putative coding 
sequence: one synonymous and the other non-synonymous, but both relatively rare, varying from 
0.05 to 0.16%, respectively. Considering ATXN3L2, three variations were observed along the 
sequence; however, these variants were rare, among our analysed samples, with percentages 
lower than 0.04%. We have notice, however, that not all SNPs annotated in databases were 
detected by us, in the resulting sequences, probably due to the low number of chromosomes 
analysed.  
Table 13 – ATXN3, ATXN3L1 and ATXN3L2 nucleotide diversities. Base positions of ATXN3 were determined based on the 
sequence annotation of Ensembl; for ATXN3L1 and ATXN3L2, the A nucleotide of the initiation codon (the corresponding first 
AAG codon in the case of ATXN3L2) is base number 1. a – in exonic regions of ATXN3-206, 207 and 209 transcripts; b - in exonic 
regions of ATXN3-015 transcript; *ancestral alleles  determined from primate orthologues alignments; Amino acids: V -  Valine; T 
– Threonine; E - Glutamic acid; R – Arginine; M- Methionine; K – Lysine; Y – Tyrosine; D - Aspartic acid; G – Glycine; NA – Not 
applicable.  
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ATXN3 ATXN3L1 ATXN3L2
(CAG)2 CAA AAG CAG CAA (CAG)17 (CAG)2 GAA CAG AAG (CAG)2 (CAA)2 CAG (CAG)3  (CGG CAG)n
    Q2        Q     K      Q      Q     Q17          Q2       E      Q      K       Q2         Q2     Q
 CAG CAA (CAG)12 (CAG)2 GAA CAG AAG (CAG)2 CAA CAC CAG CAG (CGG CAG)9  
    Q      Q     Q12          Q2       E      Q     K       Q2       Q     H     Q
(CAG)2 CAA AAG CAG CAA AAG (CAG)n (CAG)2 GAA CAG AAG (CAG)2 (CAA)2 CAG (CAG)10 
    Q2        Q     K      Q      Q      K        Qn          Q2       E      Q      K       Q2         Q2     Q
(CAG)2 CAA AAG CAG CAA (CAG)8 (CAG)2 GAA CAG AAG CTG (CAG)4 (CAG)6  
    Q2        Q     K      Q      Q     Q8         Q2       E       Q      K      L       Q4     
(CAG)3 CAA (CAG)9 (CAG)2 GAA CAG AAG (CAG)2 (CAA)2 CAG (CAG)8
    Q3       Q       Q9         Q 2      E      Q      K        Q 2        Q2      Q
(CAG)2 CAA (CAG)2 AAG (CAG)7 (CAG)2 GAA CAG AAG (CAG)2 (CAA)2 CAG (CAG)6 CAC CAG
     Q2       Q       Q2      K        Q7         Q2        E      Q      K       Q2         Q2       Q
CAG CAA (CAG)5 CAA (CAG)3 [GAG (CAG)3]2 CAA GAA CAA (CAG)2 Not described
   Q      Q       Q5       Q       Qn       (E      Q3)2    Q      E      Q      Q2
Not completly sequenced CAG CAA  (CAG)2 Not described
   Q     Q       Q2
(CAG)5 CAA (CAG)5 AGG Not described Not described
    Q5       Q       Q5       K     
Homo sapiens 
Otolemur garnetii
Callithrix jacchus 
Pan troglodytes 
Gorilla gorilla
Pongo abelii
Nomascus leucogenys
Macaca mulatta
Tarsius syrichta
5. Evolution of the (CAG)n tract in ATXN3, ATXN3L1 and ATXN3L2  
To gain insight into the processes by which the (CAG)n tracts have been accumulating variation 
throughout each paralogue evolution, we analysed sequences from all primates obtained from 
databases (Table 14). However, this analysis involved mainly a single sequence from each species, 
which did not allow us to study loci diversity. To analyse the level of polymorphism, ATXN3L1 and 
ATXN3L2 from 6 primate species were sequenced (Table 15) and data gathered with the reference 
ones. 
  
 
Analysing the compiled sequences alone, (CAG)n tract was found to be more conserved in the 
parental gene along the primate lineage, mainly in human, gorilla and orangutan, with a (CAG)2 
CAA AAG CAG CAA tract, followed by AAG and/or (CAG)n. This configuration gives rise to an 
almost pure polyQ tract, with a single K (lysine) interruption (two in gorilla). Chimp, on the other 
hand, presents a more simple CAG CAA (CAG)n configuration, encoding a pure glutamine stretch. 
The (CAG)n tract in gibbon, rhesus monkey, marmoset and bushbaby has a (CAG)n CAA (CAG)n, 
followed by a variable end.  The protein tract is pure (in gibbon) or interrupted only by a lysine in 
rhesus monkey and bushbaby, or a glutamic acid in marmoset. For ATXN3L1, the (CAG)n is also 
conserved among primates, having a (CAG)2 GAA CAG AAG (CAG)2 stretch followed  by a small 
variable end with CAA, CAG or CAC triplets. The resulting putative protein sequence is 
interrupted, generally with the Q2 E Q K Qn configuration. Marmoset and tarsier have a different 
configuration, with a smaller tract: CAA GAA CAA (CAG)2 and CAG CAA (CAG)2, respectively. If 
translated, these tracts give rise to a smaller pure (for tarsier) or almost pure (for marmoset) 
Table 14 – ATXN3, ATXN3L1 and AtXN3L2 (CAG)n tracts of several primates collected from NCBI, Ensembl and UCSC 
Genome Browser databases. 
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Chr.
Number of 
chromossomes
Sequence Chr.
Number of 
chromossomes
Sequence
1 (CAG)3 (CGG CAG)11  
4 (CAG)3 (CGG CAG)9
38 (CAG)3 (CGG CAG)8
3 (CAG)3 (CGG CAG)6
2 (CAG)3 (CGG CAG)5
10 (CAG)3 (CGG CAG)4
     Q2       E      Q      K       Q2         Q2     Q
3 CAG (CGG CAG)9  
X 8 1 CAG (CGG CAG)6  
    Q2       E       Q      K      L     Q      Q2      Q
1 (CAG)16
1 (CAG)10
X 8 2 (CAG)7 
2 (CAG)6
    Q2       E       Q      K      L     Q      Q2      Q
1 (CAG)7
X 8 1 (CAG)6  
    Q2       E       Q      K      L     Q      Q2      Q
1* (CAG)8 CAC CAG
2* (CAG)7 CAC CAG
? ? 1* CAG CAT (CAG)5 CAC CAG
4 (CAG)8 CAC CAG     
4 (CAG)6 CAC CAG     
    Q2        E      Q      K       Q2         Q2       Q
2* (CAG)2 GAA CAG AAG (CAG)2 (CAA)2 CAG 3* (CAG)6 CAC CAG     
    Q2        E      Q      K       Q2         Q2       Q
Macaca mulatta X
2
Papio
Gorilla gorilla
2 (CAG)2 GAA CAG AAG CTG CAG (CAA)2 CAG 
Pongo abelii
2 (CAG)2 GAA CAG AAG CTG CAG (CAA)2 CAG 
ATXN3L1 ATXN3L2
Pan troglodytes
3 (CAG)2 GAA CAG AAG CTG CAG (CAA)2 CAG 
Homo sapiens X 8
(CAG)2 GAA CAG AAG (CAG)2 (CAA)2 CAG 36
(CAG)2 GAA CAG AAG (CAG)2 (CAA)2 CAG 
8
Macaca fascicularis ? ?
polyglutamine stretches, which may suggest that ATXN3L1 CAG repeat has expanded and gained 
interruptions along the primate lineage. As for ATXN3L2, the (CAG)n tract is more variable. For 
gorilla, orangutan and gibbon, the (CAG)n tract is pure, whereas for  human and chimp it is highly 
interrupted by CGG codons. For the first time, a hexanucleotide repeat is observed associated 
within ataxin-3 paralogues, instead of a trinucleotide pattern. These results suggested that 
ATXN3L1 acquired interruptions in its CAG repeat region that may turn it more stable. On the 
other hand, in the case of ATXN3L2, the almost pure (CAG)n in species which diverged earlier in 
primate evolution, and the polymorphic (CGG CAG)n in humans and chimps has shown the highest 
instability associated to this locus.  
 
Table 15 - ATXN3, ATXN3L1 and ATXN3L2 (CAG)n tracts obtained by sequencing for several primates.* mark the minimum 
number of chromosomes analysed taking into account that we ignored whether the respective gene location in these species were 
in autosomal or sex chromosomes (which, in case of homozygous regions could result in different number of alleles analysed: n vs 
2n. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Comparing the complied sequences with those obtained by us through sequencing (Table 15), 
we noticed that ATXN3L1 sequences of some species may not be correctly described in databases. 
For chimp, gorilla and orangutan, observed CAG repeat configurations differed from those 
described in Table 14. This could be simply explained by the level of polymorphism associated to 
these tracts; nevertheless, all repeat tracts sequenced by us for individuals from these 3 species 
presented no variation, all sharing the same configuration and length: (CAG)2 GAA CAG AAG CTG 
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CAG (CAA)2 CAG, possibly encoding a Q2 E Q K L Q4 protein stretch. This means that this region 
may be even more conserved along the primate lineage than it has been described. For ATXN3L2, 
the (CAG)n tract of all sequenced primate samples showed a similar configuration to reference 
sequences available in databases, illustrated in Table 14; the repeat size showed, however, to be 
more variable. 
Part 2 – Insights into ATXN3L1 and ATXN3L2 functional relevance  
1. ORF predictions for ATXN3L1 and ATXN3L2 
To explore the possibility of ATXN3L1 and ATXN3L2 paralogues being transcribed, the analysis 
of the respective ORFs was performed; the obtained results are illustrated in Figure 11. ATXN3L1 
showed a complete and intact ORF that is maintained in the 7 primate species previously analysed 
by us. These results confirmed the hypothesis that this paralogue is likely to be subjected to 
selective constrains that are keeping its sequence on check and almost intact along the primate 
lineage. On the other hand, for ATXN3L2, there are no intact ORFs predicted in any of the primate 
sequences; instead, only short ORFs of approximately 200 bp or less are expected.  
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Figure 11 - Predicted ORFs for ATXN3L1 and ATXN3L2 primate sequences, calculated by NCBI ORF finder. Obtained ORF 
predictions are illustrated in blue and the corresponding sizes are described on the right side of each illustration.  
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ATXN3 
ATXN3L1 
2. Analysis of ATXN3L1 putative protein domains in comparison to the 
parental ATXN3 
To understand how differences on the ATXN3L1 sequence relatively to the parental gene 
could possibly alter its putative coding protein, the principal domains and regions important to 
ataxin-3 functions were compared between the two sequences (Figure 12). 
 
 
 
 
 
 
 
 
 
 
 
 
The catalytic Josephin domain was found to be highly conserved in ATXN3L1, with the 
important catalytic triad, composed of C14, H119 and N134, totally preserved. In addition, NES77 
and NES141 are composed mostly by the same amino acids. Additionally, UIM1 of ATXN3L1 is 
quite similar to the parental protein, although the same cannot be observed for UIM2 and UIM3, 
which possess more amino acid changes and some gaps. The NLS273 is highly different when 
compared to the parental protein. Finally, the polyQ tract, as described above, has some 
alterations that turned it more interrupted in ATXN3L1. It is important to understand that despite 
these two protein sequences present some amino acid divergences, these small alterations may 
not correspond to a significant change on the protein conformation and/or function. To better 
understand this divergence features will be necessary to proceed with more functional studies to 
characterize the putative ATXN3L1 protein sequence.  
Figure 12 – Comparison between ATXN3 and ATXN3L1 protein coding sequences. Dots show conserved 
amino acids and letters show the amino acid changes. The main functional Josephin domain, the ubiquitin 
interacting motifs (UIMs) and polyQ tract are highlighted.  Other important sites of the protein are also 
represented, as the nuclear export signal (NES) and the nuclear localization signal (NLS). marks amino acids 
composing the catalytic triad; 0 marks the conserved serine-232 and serine-260 in UIM1 and UIM2, respectively. 
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3. mRNA expression profile of ATXN3L1 in humans 
We tested for the presence of ATXN3L1 in cDNA from different human body tissues by using 
primers designed to specifically amplify this putative transcript. First, to overview the 
transcriptional pattern among the 16 selected tissues, two of the four planned amplifications 
were done at a lower temperature (56°C). Primers for the amplification of actin cDNA were used 
as control (Figure 13).  
 
 
 
 
 
 
  
With these conditions, we have found discordant results for the two amplifications tested. By 
using E8-9 primers, amplification was obtained in only two tissues (prostate and testis), whereas 
for E10-11, amplified products were observed in brain, liver, testis, colon and ovary. In both cases, 
testis cDNA was the tissue for which we observed more amplified product, allowing the formation 
of a clearly visible gel band (a similar amplification pattern for actin cDNA in all tissues discarded 
the possible heterogeneity among different tissue samples). Sequencing of each band showed 
that all amplified bands were specific human ATXN3L1 sequences. Additionally, E10-11 primers 
amplified a longer fragment (180 bp) than the expected 110 bp on brain cDNA; we still need to 
clarify the reason for this difference on fragment sizes.  
To increase the specificity of ATXN3L1 cDNA amplification, the experiment was repeated by 
applying new different condition of amplification. We increased the annealing temperature to 
58°C on the PCR reaction and tested the amplification with the four designed pairs of primers, on 
the 8 cDNA samples for which we had previously observed amplification (Figure 13). 
 
 
Size  
150bp 
130bp 
110bp 
180bp 
 
Prostate  
Heart  Testis   Colon  Esophag
e   
Brain  Liver Spleen S. intestine  
S. muscle  Kidney  Thyorid   Thymus  Thraquea  Bladder  
Ovary  Neg. control  
Primer pair 
Actin 
E8-9 
E10-11 
Figure 13 – ATXN3L1 transcriptional pattern of 16 human tissues using E8-9 and E10-11 primers. The 
human tissues used are listed at the bottom of the image and the sizes of obtained bands are labeled on the 
right side. Actin cDNA was amplified as a control. 
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After applying the new conditions, testis was the only tissue where products were constantly 
and clearly amplified. To clarify the transcription pattern of ATXN3L1, a better optimization of the 
amplification protocol must be performed.  
 
 
 
 
 
 
Figure 14 - ATXN3L1 transcriptional pattern for the 4 designed pairs of primers for 8 human 
tissues. Actin cDNA was amplified as control. 
Size  
150bp 
110bp 
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UTR-E2 
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E10-11 
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Neg. control 
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Chapter 4 
Discussion  
Retrotransposition and retrogenes are gaining increasing attention as recent studies have 
shown that they may play an important role in genome evolution and in the formation of new 
genes.1, 72  
This project allowed us to investigate the evolution of ataxin-3 paralogues formed by 
retrotransposition events, and to shed light on the functional relevance of these copies. Our 
results showed that ATXN3 gene has been on the origin of many different retrocopies along 
the mammalian lineage. Two of these retrocopies, ATXN3L1 and ATXN3L2, were found to have 
orthologues in several species from the primate lineage. The remaining copies, all diverging 
from each other, resulted from independent-origin retrotransposition events occurred after 
the speciation of several mammalian species. These observations are compatible with studies 
performed by Pan and Zhang (2007 and 2009) where they explain that a burst of young and 
independent retrogenes has recently arisen in several species branches, mainly in mammalian 
genomes. 2, 73 The key factor underlying this important active process, that has been shaping 
the dynamics of mammalian genomes, might have been the recruitment of specific L1 
retrotransposons in mammals.2, 73  
In the case of ATXN3L1 and ATXN3L2, the identification of several orthologues in the 
primate lineage suggested an ancestral origin for each one of these copies, before the split of 
several primate clades, with their evolution until these days. Our results suggested that the 
two retrocopies have independent origins, with ATXN3L1 as the most ancient copy (63 MYA), 
followed by the birth of ATXN3L2, about 35 MYA. Across their evolution, these copies had the 
chance to become functional or remain as non-relevant pseudogenes, having consequently 
more or less influence in the respective genomes of the considered species. Our results have 
shown some evidences that ATXN3L1 is being conserved and its ORF kept in check. In addition, 
our results suggested that ATXN3L1 is more likely to be transcribed than ATXN3L2. This 
difference may have resulted from the genomic background where copies were inserted. A 
study by Emerson et al. (2004) claims that retrogenes are not randomly located on 
chromosomes, but that genes are more likely to be retroposed into and/or out-of the X 
chromosome in mammals.74 The authors demonstrated that, during evolution of human and 
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mouse genomes, the mammalian X chromosome has generated and recruited a 
disproportionately high number of functional retroposed genes, whereas the autosomes 
experienced lower gene turnover. 8, 74 Therefore, it is interesting to notice that the most 
conserved ATXN3 retrocopy, ATXN3L1, is located on the X chromosome, whereas ATXN3L2 
(suggested by our results to be, most likely, a processed pseudogene) resides in an autossome.  
As it was previously described, to become fixed in a given species genome, retrocopies 
must arise in the germ line and the gene source must be expressed at that time.1 ATXN3 is 
ubiquitously present in human tissues and cell types however, the retropositions of ATXN3L1 
and ATXN3L2 occurred, not in the human species, but in an ancestor of Haplorrhines and 
Catarrhines, respectively. 25, 38 Thus, to be feasible the occurrence of retrotransposition events 
from ATXN3, this gene must have been transcribed in the germ line of these ancestral species. 
The analysis of the (CAG)n tract of ATXN3, among different primate species, is a key factor 
to understand the process of repeat instability over the primate lineage until reaching the 
expanded/pathogenic range  in humans. In the parental gene, the repeat tract configuration 
has been maintained stable along the primate lineage, varying mainly on the repeat size, which 
increased over time. Most of the studies have described a range between 14-40 in humans, 14-
20 in chimps, 8-11 in gorillas and 24-25 in orangutans.75 According to Andrés et al. (2004), 
humans show, not only a higher mean number of repeats than other species, but also a higher 
variance and coefficient of variation, with a decreasing trend observed as more anciently 
diverged primates are analysed. Thus, a relationship has been suggested between variability 
levels and expansion potential. In addition, the authors hypothesized the existence of some 
balancing selection favouring the existence of different alleles in human populations that 
would maintain the high (CAG)n diversity currently observed in our species.75  
As for ATXN3L1, the CAG repeat showed a poorly polymorphic and highly interrupted tract 
across the primate lineage, whereas ATXN3L2 presented a pure (CAG)n in some species, and a 
polymorphic hexanucleotide repeat in humans and chimpanzees. This recent acquisition of a 
repetitive CGGCAG resulted, probably, from a CAG to CGG mutation followed by instability 
that encompassed the six bases instead of the CAG alone. 
In addition, studies on the CAG region of both parental and ATXN3 paralogues can be 
important to gain insight into the involvement of these repetitive tracts in both pathological 
and non-pathological states of the protein. In fact, Schaefer et al. (2012) have claimed that 
(CAG)n tracts are not randomly distributed in the genome.
76 Also, recent studies have 
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demonstrated that the polyQ tract may actually have a function in repeat-containing proteins. 
In fact, we can observe a biased involvement of these proteins towards functions related to 
transcriptional regulation and nuclear localization.77, 78 Moreover, recent studies have 
suggested the involvement of polyQ repeats in protein-protein interaction networks, by 
stabilizing structural changes to facilitate the interaction between own coiled-coil regions with 
coiled-coil regions of other proteins (Figure 14).76 These facts suggest that (CAG)n tracts can 
actually be subjected to selective pressures, in order to maintain a possible functional role in 
the protein context.  
 
 
 
 
Analysing ORF predictions for both ATXN3L1 and ATXN3L2, it was evident that the first 
copy, although more ancient, maintained its intact putative coding sequence. In opposition, 
the most recent retrocopy ATXN3L2 displayed a disrupted ORF, with maximum length 
fragments of 200 bp predicted as alternative ORFs. These facts come to reinforce that both 
copies have accumulated genetic differences relatively to the parental gene along their 
evolution; nevertheless, ATXN3L1 seems to be under selective constrains that might be 
keeping its sequence in check whereas ATXN3L2 has accumulated premature stop codons that 
interrupted its original sequence. Yet, the short ORF of ATXN3L2 may be transcribed into 
mRNA and play a trans-regulatory role in the expression of the parental gene. Indeed, it was 
recently found that some mammalian retropseudogenes have evolved the capacity to encode 
small interference RNAs, important for the regulation of their parental source genes.   
Concerning the analysis of ATXN3L1 expression in human tissues, our results have 
demonstrated that this paralogue is expressed, at least, in human testis. Results for other 
human tissues, such as brain, prostate, colon, liver and ovary, were less clear and, thus, need 
to be confirmed with further analyses. By comparing our results with expression data available 
in NCBI (EST profile) and in the Human Protein Atlas (http://www.proteinatlas.org/, updated at 
Figure 14 – Possible role for the polyQ stretch in protein-protein interactions: upon 
interaction with a protein partner, the polyQ region adopts a coiled-coil structure. (adapted 
from Schaefer, 2012)76 
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11/11/2011), data is not consensual. Figure 15 shows a summary of the ATXN3L1 expression 
levels, and Figure A7 of the appendix section a more complete version of these data.  
 
 
 
Figure 15 – ATXN3L1 expression levels in different human organs/tissues. (data from the Human Protein Atlas: 
http://www.proteinatlas.org/ENSG00000123594) 
 
  It is important, however, to notice that expression patterns annotated in The Human 
Protein Atlas are based on antibody assays classified as “Low Reliability” in the case of 
ATXN3L1. On the other hand, ATXN3L1 expression patterns consulted in the NCBI – UniGene – 
EST Profile are illustrated in Figure A8 of the appendix section. Here, the expression levels 
were measured by EST counts in unbiased cDNA libraries. Testis and brain are the only human 
body tissues where ATXN3L1 is shown to be expressed, with higher levels of expression in 
testis. These data are, in fact, more similar to our results, but no further conclusions can be 
taken before confirming the obtained results 
By comparing the principal domains of ATXN3 and ATXN3L1 proteins, we observed a 
conserved Josephin domain (catalytic domain), NES77, NES141 and UIM1, whereas less 
similarity was found for the remaining regions NLS273, UIM2 and UIM3. As the catalytic 
domain is the most conserved one (with intact catalytic sites: C14, H119 and N134), it can be 
hypothesized that ATXN3L1 is likely to exert an ubiquitin protease activity as the parental 
ATXN3. The two other important residues in UIMs (serine-232 and serine-260 in UIM1 and 
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UIM2), as well as the UIM1 itself, are also conserved in ATXN3L1 suggesting that ubiquitin 
interactions can also be carried out by this retrocopy. However, possible functions of ATXN3L1 
cannot be speculated based only on its conserved domains. More functional studies must be 
performed, for example, in order to explore common binding partners to the parental protein.   
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Chapter 5 
Final remarks and future perspectives   
The general aims traced for this project were accomplished, but still, there are techniques 
here developed that can be optimized, as well as the enlargement of sample sizes in order to 
enrich and reinforce the obtained results.  
From our study, it was possible to conclude that the analysis of paralogue genes involved in 
neurodegenerative diseases can be of great importance to gain insight into the mechanisms of 
pathogenesis. Namely, on Machado-Joseph disease, the ATXN3L1 was observed to be transcribed 
in human tissues; expression patterns will be assessed next through the optimization of specific 
amplifications of ATXN3L1 cDNA. At the protein level, ATXN3L1 possesses a highly conserved 
catalytic domain. Next, to detect the endogenous protein in human tissues, an anti-ATXN3L1 
specific antibody can be generated to perform Western blot and immunohistochemistry. 
Additionally, future studies on the protein characterization will allow us to evaluate if this 
retrocopy has evolved towards functional diversification (neofunctionalization or 
neosubfunctionalization) relatively to the parental protein. To test if ATXN3L1 shares some of the 
most important molecular interactors (common binding partners) with ATXN3, one could detect 
common binding partners by co-immunoprecipitation with the transcriptional coactivators and 
DNA repair proteins that interact with the parental ataxin-3. 
 
Further studies can be made, also, to confirm if the small ATXN3L2 ORFs predicted in this 
study are transcribed or not. This can be done by following the same approach we used here for 
ATXN3L1: the design of specific primers to amplify concatenated regions corresponding to ATXN3 
exons, in gene-specific nucleotides with highly conserved sites across species within orthologues. 
If the transcription of ATXN3L2 occurs, one could explore the possibility of them being encoding 
small interference RNAs and acting as trans-regulatory factors of ATXN3. 
University of Aveiro – Master’s in Molecular Biomedicine 
IPATIMUP 
2012 
 
66 
 
 
 
 
 
 
 
 
 
 
  
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
References 
  
  
 
 
Evolution and Functional Relevance of Ataxin-3 Paralogues 
Maria Inês Martins  
 
69 
  
 
References 
 
1. Kaessmann H, Vinckenbosch N, Long M. RNA-based gene duplication: mechanistic and evolutionary insights. Nat Rev Genet. Jan 
2009;10(1):19-31. 
2. Pan D, Zhang L. Burst of young retrogenes and independent retrogene formation in mammals. PLoS One. 2009;4(3):e5040. 
3. Ostertag EM, Kazazian HH, Jr. Biology of mammalian L1 retrotransposons. Annu Rev Genet. 2001;35:501-538. 
4. Kazazian HH, Jr., Goodier JL. LINE drive. retrotransposition and genome instability. Cell. Aug 9 2002;110(3):277-280. 
5. Vinckenbosch N, Dupanloup I, Kaessmann H. Evolutionary fate of retroposed gene copies in the human genome. Proc Natl Acad 
Sci U S A. Feb 28 2006;103(9):3220-3225. 
6. Cordaux R, Batzer MA. The impact of retrotransposons on human genome evolution. Nat Rev Genet. Oct 2009;10(10):691-703. 
7. Esnault C, Maestre J, Heidmann T. Human LINE retrotransposons generate processed pseudogenes. Nat Genet. Apr 
2000;24(4):363-367. 
8. Betran E, Thornton K, Long M. Retroposed new genes out of the X in Drosophila. Genome Res. Dec 2002;12(12):1854-1859. 
9. Burki F, Kaessmann H. Birth and adaptive evolution of a hominoid gene that supports high neurotransmitter flux. Nat Genet. Oct 
2004;36(10):1061-1063. 
10. Carlson KM, Andresen JM, Orr HT. Emerging pathogenic pathways in the spinocerebellar ataxias. Curr Opin Genet Dev. Jun 
2009;19(3):247-253. 
11. Teive HA. Spinocerebellar ataxias. Arq Neuropsiquiatr. Dec 2009;67(4):1133-1142. 
12. Soong BW, Paulson HL. Spinocerebellar ataxias: an update. Curr Opin Neurol. Aug 2007;20(4):438-446. 
13. Bettencourt C, Lima M. Machado-Joseph Disease: from first descriptions to new perspectives. Orphanet J Rare Dis. 2011;6:35. 
14. Kieling C, Morales Saute JA, Jardim LB. When ataxia is not just ataxia. Nat Clin Pract Neurol. May 2007;3(5):E2. 
15. Coutinho P, Andrade C. Autosomal dominant system degeneration in Portuguese families of the Azores Islands. A new genetic 
disorder involving cerebellar, pyramidal, extrapyramidal and spinal cord motor functions. Neurology. Jul 1978;28(7):703-709. 
16. Jardim LB, Silveira I, Pereira ML, et al. A survey of spinocerebellar ataxia in South Brazil - 66 new cases with Machado-Joseph 
disease, SCA7, SCA8, or unidentified disease-causing mutations. J Neurol. Oct 2001;248(10):870-876. 
17. Vale J, Bugalho P, Silveira I, Sequeiros J, Guimaraes J, Coutinho P. Autosomal dominant cerebellar ataxia: frequency analysis and 
clinical characterization of 45 families from Portugal. Eur J Neurol. Jan 2010;17(1):124-128. 
18. Zhao Y, Tan EK, Law HY, Yoon CS, Wong MC, Ng I. Prevalence and ethnic differences of autosomal-dominant cerebellar ataxia in 
Singapore. Clin Genet. Dec 2002;62(6):478-481. 
19. Tang B, Liu C, Shen L, et al. Frequency of SCA1, SCA2, SCA3/MJD, SCA6, SCA7, and DRPLA CAG trinucleotide repeat expansion in 
patients with hereditary spinocerebellar ataxia from Chinese kindreds. Arch Neurol. Apr 2000;57(4):540-544. 
20. van de Warrenburg BP, Sinke RJ, Verschuuren-Bemelmans CC, et al. Spinocerebellar ataxias in the Netherlands: prevalence and 
age at onset variance analysis. Neurology. Mar 12 2002;58(5):702-708. 
21. Schols L, Amoiridis G, Buttner T, Przuntek H, Epplen JT, Riess O. Autosomal dominant cerebellar ataxia: phenotypic differences in 
genetically defined subtypes? Ann Neurol. Dec 1997;42(6):924-932. 
22. Maruyama H, Izumi Y, Morino H, et al. Difference in disease-free survival curve and regional distribution according to subtype of 
spinocerebellar ataxia: a study of 1,286 Japanese patients. Am J Med Genet. Jul 8 2002;114(5):578-583. 
23. Martins S, Calafell F, Gaspar C, et al. Asian origin for the worldwide-spread mutational event in Machado-Joseph disease. Arch 
Neurol. Oct 2007;64(10):1502-1508. 
24. Takiyama Y, Nishizawa M, Tanaka H, et al. The gene for Machado-Joseph disease maps to human chromosome 14q. Nat Genet. 
Jul 1993;4(3):300-304. 
University of Aveiro – Master’s in Molecular Biomedicine 
IPATIMUP 
2012 
 
70 
 
25. Ichikawa Y, Goto J, Hattori M, et al. The genomic structure and expression of MJD, the Machado-Joseph disease gene. J Hum 
Genet. 2001;46(7):413-422. 
26. Bettencourt C, Santos C, Montiel R, et al. Increased transcript diversity: novel splicing variants of Machado-Joseph disease gene 
(ATXN3). Neurogenetics. May 2010;11(2):193-202. 
27. Kawaguchi Y, Okamoto T, Taniwaki M, et al. CAG expansions in a novel gene for Machado-Joseph disease at chromosome 
14q32.1. Nat Genet. Nov 1994;8(3):221-228. 
28. Wang JL, Xiao B, Cui XX, et al. Analysis of SCA2 and SCA3/MJD repeats in Parkinson's disease in mainland China: genetic, clinical, 
and positron emission tomography findings. Mov Disord. Oct 15 2009;24(13):2007-2011. 
29. Gilman S. The spinocerebellar ataxias. Clin Neuropharmacol. Nov-Dec 2000;23(6):296-303. 
30. Maruyama H, Nakamura S, Matsuyama Z, et al. Molecular features of the CAG repeats and clinical manifestation of Machado-
Joseph disease. Hum Mol Genet. May 1995;4(5):807-812. 
31. van de Warrenburg BP, Hendriks H, Durr A, et al. Age at onset variance analysis in spinocerebellar ataxias: a study in a Dutch-
French cohort. Ann Neurol. Apr 2005;57(4):505-512. 
32. Kawakami H, Maruyama H, Nakamura S, et al. Unique features of the CAG repeats in Machado-Joseph disease. Nat Genet. Apr 
1995;9(4):344-345. 
33. Maciel P, Gaspar C, DeStefano AL, et al. Correlation between CAG repeat length and clinical features in Machado-Joseph disease. 
Am J Hum Genet. Jul 1995;57(1):54-61. 
34. Carvalho DR, La Rocque-Ferreira A, Rizzo IM, Imamura EU, Speck-Martins CE. Homozygosity enhances severity in spinocerebellar 
ataxia type 3. Pediatr Neurol. Apr 2008;38(4):296-299. 
35. Panigrahi GB, Lau R, Montgomery SE, Leonard MR, Pearson CE. Slipped (CTG)*(CAG) repeats can be correctly repaired, escape 
repair or undergo error-prone repair. Nat Struct Mol Biol. Aug 2005;12(8):654-662. 
36. Martins S, Calafell F, Wong VC, Sequeiros J, Amorim A. A multistep mutation mechanism drives the evolution of the CAG repeat 
at MJD/SCA3 locus. Eur J Hum Genet. Aug 2006;14(8):932-940. 
37. Djian P, Hancock JM, Chana HS. Codon repeats in genes associated with human diseases: fewer repeats in the genes of 
nonhuman primates and nucleotide substitutions concentrated at the sites of reiteration. Proc Natl Acad Sci U S A. Jan 9 
1996;93(1):417-421. 
38. Trottier Y, Cancel G, An-Gourfinkel I, et al. Heterogeneous intracellular localization and expression of ataxin-3. Neurobiol Dis. 
Nov 1998;5(5):335-347. 
39. Bilen J, Bonini NM. Genome-wide screen for modifiers of ataxin-3 neurodegeneration in Drosophila. PLoS Genet. Oct 
2007;3(10):1950-1964. 
40. Macedo-Ribeiro S, Cortes L, Maciel P, Carvalho AL. Nucleocytoplasmic shuttling activity of ataxin-3. PLoS One. 2009;4(6):e5834. 
41. Paulson HL, Das SS, Crino PB, et al. Machado-Joseph disease gene product is a cytoplasmic protein widely expressed in brain. 
Ann Neurol. Apr 1997;41(4):453-462. 
42. Bichelmeier U, Schmidt T, Hubener J, et al. Nuclear localization of ataxin-3 is required for the manifestation of symptoms in 
SCA3: in vivo evidence. J Neurosci. Jul 11 2007;27(28):7418-7428. 
43. Chai Y, Koppenhafer SL, Shoesmith SJ, Perez MK, Paulson HL. Evidence for proteasome involvement in polyglutamine disease: 
localization to nuclear inclusions in SCA3/MJD and suppression of polyglutamine aggregation in vitro. Hum Mol Genet. Apr 
1999;8(4):673-682. 
44. Mukhopadhyay D, Riezman H. Proteasome-independent functions of ubiquitin in endocytosis and signaling. Science. Jan 12 
2007;315(5809):201-205. 
45. Todi SV, Laco MN, Winborn BJ, Travis SM, Wen HM, Paulson HL. Cellular turnover of the polyglutamine disease protein ataxin-3 
is regulated by its catalytic activity. J Biol Chem. Oct 5 2007;282(40):29348-29358. 
46. Chou AH, Yeh TH, Ouyang P, Chen YL, Chen SY, Wang HL. Polyglutamine-expanded ataxin-3 causes cerebellar dysfunction of 
SCA3 transgenic mice by inducing transcriptional dysregulation. Neurobiol Dis. Jul 2008;31(1):89-101. 
Evolution and Functional Relevance of Ataxin-3 Paralogues 
Maria Inês Martins  
 
71 
  
47. Nicastro G, Todi SV, Karaca E, Bonvin AM, Paulson HL, Pastore A. Understanding the role of the Josephin domain in the PolyUb 
binding and cleavage properties of ataxin-3. PLoS One. 2010;5(8):e12430. 
48. Masino L, Musi V, Menon RP, et al. Domain architecture of the polyglutamine protein ataxin-3: a globular domain followed by a 
flexible tail. FEBS Lett. Aug 14 2003;549(1-3):21-25. 
49. Harris GM, Dodelzon K, Gong L, Gonzalez-Alegre P, Paulson HL. Splice isoforms of the polyglutamine disease protein ataxin-3 
exhibit similar enzymatic yet different aggregation properties. PLoS One. 2010;5(10):e13695. 
50. Scheel H, Tomiuk S, Hofmann K. Elucidation of ataxin-3 and ataxin-7 function by integrative bioinformatics. Hum Mol Genet. Nov 
1 2003;12(21):2845-2852. 
51. Mueller T, Breuer P, Schmitt I, Walter J, Evert BO, Wullner U. CK2-dependent phosphorylation determines cellular localization 
and stability of ataxin-3. Hum Mol Genet. Sep 1 2009;18(17):3334-3343. 
52. Weeks SD, Grasty KC, Hernandez-Cuebas L, Loll PJ. Crystal structure of a Josephin-ubiquitin complex: evolutionary restraints on 
ataxin-3 deubiquitinating activity. J Biol Chem. Feb 11 2011;286(6):4555-4565. 
53. Matos CA, de Macedo-Ribeiro S, Carvalho AL. Polyglutamine diseases: the special case of ataxin-3 and Machado-Joseph disease. 
Prog Neurobiol. Sep 15 2011;95(1):26-48. 
54. Ferrigno P, Silver PA. Polyglutamine expansions: proteolysis, chaperones, and the dangers of promiscuity. Neuron. Apr 
2000;26(1):9-12. 
55. Muchowski PJ, Schaffar G, Sittler A, Wanker EE, Hayer-Hartl MK, Hartl FU. Hsp70 and hsp40 chaperones can inhibit self-assembly 
of polyglutamine proteins into amyloid-like fibrils. Proc Natl Acad Sci U S A. Jul 5 2000;97(14):7841-7846. 
56. Chai Y, Wu L, Griffin JD, Paulson HL. The role of protein composition in specifying nuclear inclusion formation in polyglutamine 
disease. J Biol Chem. Nov 30 2001;276(48):44889-44897. 
57. Li F, Macfarlan T, Pittman RN, Chakravarti D. Ataxin-3 is a histone-binding protein with two independent transcriptional 
corepressor activities. J Biol Chem. Nov 22 2002;277(47):45004-45012. 
58. Evert BO, Araujo J, Vieira-Saecker AM, et al. Ataxin-3 represses transcription via chromatin binding, interaction with histone 
deacetylase 3, and histone deacetylation. J Neurosci. Nov 1 2006;26(44):11474-11486. 
59. Gunawardena S, Her LS, Brusch RG, et al. Disruption of axonal transport by loss of huntingtin or expression of pathogenic polyQ 
proteins in Drosophila. Neuron. Sep 25 2003;40(1):25-40. 
60. Donaldson KM, Li W, Ching KA, Batalov S, Tsai CC, Joazeiro CA. Ubiquitin-mediated sequestration of normal cellular proteins into 
polyglutamine aggregates. Proc Natl Acad Sci U S A. Jul 22 2003;100(15):8892-8897. 
61. Paulson HL, Perez MK, Trottier Y, et al. Intranuclear inclusions of expanded polyglutamine protein in spinocerebellar ataxia type 
3. Neuron. Aug 1997;19(2):333-344. 
62. Goti D, Katzen SM, Mez J, et al. A mutant ataxin-3 putative-cleavage fragment in brains of Machado-Joseph disease patients and 
transgenic mice is cytotoxic above a critical concentration. J Neurosci. Nov 10 2004;24(45):10266-10279. 
63. Yoshizawa T, Yamagishi Y, Koseki N, et al. Cell cycle arrest enhances the in vitro cellular toxicity of the truncated Machado-
Joseph disease gene product with an expanded polyglutamine stretch. Hum Mol Genet. Jan 1 2000;9(1):69-78. 
64. Haacke A, Broadley SA, Boteva R, Tzvetkov N, Hartl FU, Breuer P. Proteolytic cleavage of polyglutamine-expanded ataxin-3 is 
critical for aggregation and sequestration of non-expanded ataxin-3. Hum Mol Genet. Feb 15 2006;15(4):555-568. 
65. Wellington CL, Ellerby LM, Hackam AS, et al. Caspase cleavage of gene products associated with triplet expansion disorders 
generates truncated fragments containing the polyglutamine tract. J Biol Chem. Apr 10 1998;273(15):9158-9167. 
66. Hubener J, Vauti F, Funke C, et al. N-terminal ataxin-3 causes neurological symptoms with inclusions, endoplasmic reticulum 
stress and ribosomal dislocation. Brain. Jul 2011;134(Pt 7):1925-1942. 
67. Costa Mdo C, Paulson HL. Toward understanding Machado-Joseph disease. Prog Neurobiol. May 2012;97(2):239-257. 
68. Fujigasaki H, Uchihara T, Koyano S, et al. Ataxin-3 is translocated into the nucleus for the formation of intranuclear inclusions in 
normal and Machado-Joseph disease brains. Exp Neurol. Oct 2000;165(2):248-256. 
69. Warrick JM, Morabito LM, Bilen J, et al. Ataxin-3 suppresses polyglutamine neurodegeneration in Drosophila by a ubiquitin-
associated mechanism. Mol Cell. Apr 1 2005;18(1):37-48. 
University of Aveiro – Master’s in Molecular Biomedicine 
IPATIMUP 
2012 
 
72 
 
70. Crespo-Barreto J, Fryer JD, Shaw CA, Orr HT, Zoghbi HY. Partial loss of ataxin-1 function contributes to transcriptional 
dysregulation in spinocerebellar ataxia type 1 pathogenesis. PLoS Genet. Jul 2010;6(7):e1001021. 
71. Bowman AB, Lam YC, Jafar-Nejad P, et al. Duplication of Atxn1l suppresses SCA1 neuropathology by decreasing incorporation of 
polyglutamine-expanded ataxin-1 into native complexes. Nat Genet. Mar 2007;39(3):373-379. 
72. Kaessmann H. Genetics. More than just a copy. Science. Aug 21 2009;325(5943):958-959. 
73. Pan D, Zhang L. Quantifying the major mechanisms of recent gene duplications in the human and mouse genomes: a novel 
strategy to estimate gene duplication rates. Genome Biol. 2007;8(8):R158. 
74. Emerson JJ, Kaessmann H, Betran E, Long M. Extensive gene traffic on the mammalian X chromosome. Science. Jan 23 
2004;303(5657):537-540. 
75. Andres AM, Soldevila M, Lao O, et al. Comparative genetics of functional trinucleotide tandem repeats in humans and apes. J 
Mol Evol. Sep 2004;59(3):329-339. 
76. Schaefer MH, Wanker EE, Andrade-Navarro MA. Evolution and function of CAG/polyglutamine repeats in protein-protein 
interaction networks. Nucleic Acids Res. May 1 2012;40(10):4273-4287. 
77. Harrison PM. Exhaustive assignment of compositional bias reveals universally prevalent biased regions: analysis of functional 
associations in human and Drosophila. BMC Bioinformatics. 2006;7:441. 
78. Alba MM, Guigo R. Comparative analysis of amino acid repeats in rodents and humans. Genome Res. Apr 2004;14(4):549-554. 
79.    Jobling MA, Hurles, ME, Tyler-Smith C. Human EvolutionaryGenetics – Origins, Peoples & Disease. Garland Publishing (2004) 
 
  
  
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Appendix  
 
 
  
  
 
 
 
Evolution and Functional Relevance of Ataxin-3 Paralogues 
Maria Inês Martins  
 
i 
  
Appendix  
 
 
Figure A1 – Alignment of all sequences searched on Ensembl, NCBI and UCSC Genome Browser databases. From top to bottom: Gallus 
gallus as outgroup; ATXN3 coding sequences for primates; ATXN3 coding sequences for non-primate mammals; ATXN3L1 for primates; 
ATXN3L2 for primates; ATXN3L? of primates and non-primate mammals. The human exons present in transcript ATXN3-001 were annotated in 
the ATXN3 coding sequence to serve as reference. Green annotations correspond to sequence portions added to those sequences obtained 
from trace archives.  
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 Table A1– Matrix of genetic distances among ATXN3, ATXN3L1 and ATXN3L2 of several primates. Cells with darker background represent higher 
similarity between two sequences, whereas lighter cells show lower similarity. Notably, a lighter gray means further apart while darker means closer 
together. The longest distance in the tree is white and the shortest distance is black (may not be zero).  
 
 
Evolution and Functional Relevance of Ataxin-3 Paralogues 
Maria Inês Martins  
 
iii 
  
 
 
Table A2 -– Matrix of genetic distances among ATXN3, ATXN3L1 and ATXN3L2 of several primates, without the CAG tract. Cells with darker background represent higher similarity 
between two sequences, whereas lighter cells show lower similarity. Notably, a lighter gray means further apart while darker means closer together. The longest distance in the tree is 
white and the shortest distance is black (may not be zero). 
Table A3 - Matrix of genetic distances among ATXN3, ATXN3L1 and ATXN3L2 Josephin domain of several primates. Cells with darker background represent higher similarity between two 
sequences, whereas lighter cells show lower similarity. Notably, A lighter gray means further apart while darker means closer together. The longest distance in the tree is white and the shortest 
distance is black (may not be zero) 
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Figure A2 –Phylogenetic tree of ATXN3, ATXN3L1 and ATXN3L2 for primates, without the GAG tract, based on the genetic 
distances presented on Table A2. Gallus gallus was used as outgroup. 
 
 
Figure A3 – Phylogenetic tree of ATXN3, ATXN3L1 and ATXN3L2 Josephin domain for primates, based on the genetic distances 
presented on Table A3. Gallus gallus was used as outgroup.  
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Table A4 - Matrix of genetic distances among ATXN3, ATXN3L1 and ATXN3L2 complete sequences of several mammals. Cells with darker background represent higher similarity between 
two sequences, whereas lighter cells show lower similarity. Notably, a lighter gray means further apart while darker means closer together. The longest distance in the tree is white and the 
shortest distance is black (may not be zero). Continue on the next page. 
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Table A4 - Continuation 
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Table A5 - Matrix of genetic distances among ATXN3, ATXN3L1 and ATXN3L2 of several mammals, without the (CAG)n tract. Cells with darker background represent higher 
similarity between two sequences, whereas lighter cells show lower similarity. Notably, a lighter gray means further apart while darker means closer together. The longest 
distance in the tree is white and the shortest distance is black (may not be zero). Continue on the next page. 
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Table A5 - Continuation 
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Table A6 - Matrix of genetic distances among ATXN3, ATXN3L1 and ATXN3L2 Josephin domain of several mammals. Cells with darker background represent higher similarity  
between two sequences, whereas lighter cells show lower similarity. Notably, a lighter gray means further apart while darker means closer together. The longest distance 
 in the tree is white and the shortest distance is black (may not be zero). Continue on the next page. 
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Table A6 - Continuation 
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Figure A4 – Phylogenetic tree of ATXN3, ATXN3L1 and ATXN3L2 for mammals, without the GAG tract, based on the genetic 
distances presented on Table A5. Gallus gallus was used as outgroup. 
 
 
Figure A5 – Phylogenetic tree of ATXN3, ATXN3L1 and ATXN3L2 Josephin domain for mammals, based on the genetic distances 
presented on table A6. Gallus gallus was used as outgroup.  
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Figure A6 – Phylogeny of extant primate groups and corresponding date of branching splits.79 
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Figure A7 - ATXN3L1 expression levels in different human organs/tissues. (data from the Human Protein Atlas: 
http://www.proteinatlas.org/ENSG00000123594) 
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Figure A8 - ATXN3L1 expression levels in different human 
organs/tissues. (data from NCBI – UniGene – EST Profile data base: 
http://www.ncbi.nlm.nih.gov/UniGene/ESTProfileViewer.cgi?uglis
t=Hs.382641) 
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